<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet type='text/xsl' href='https://www.pharmaceutical-technology.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl'?><!-- sitemap-generator-url='http://www.arnebrachhold.de' sitemap-generator-version='4.1.19' -->
<!-- generated-on='April 14, 2026 10:55 pm' -->
<urlset xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd' xmlns='http://www.sitemaps.org/schemas/sitemap/0.9'>	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshorizon-pharma-agrees-to-buy-rare-disease-firm-raptor-for-800m-5003057/</loc>
		<lastmod>2016-09-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/deepening-european-ties-a-look-at-the-potential-impact-of-recent-irp-changes-in-ireland-html/</loc>
		<lastmod>2021-11-02T03:28:01+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsscientists-find-new-immunotherapy-effective-against-pancreatic-cancer-5001080/</loc>
		<lastmod>2016-09-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-researchers-work-to-develop-new-epilepsy-drugs-5001316/</loc>
		<lastmod>2016-09-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureaugusts-top-stories-pfizer-astrazeneca-15bn-deal-cinven-buys-bioclinica-for-14bn-5001872/</loc>
		<lastmod>2021-10-29T05:36:48+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-philippines-pharmaceutical-market-to-grow-at-a-cagr-of-37-to-reach-41bn-by-2020-4996473/</loc>
		<lastmod>2016-09-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-istituto-biochimico-italiano-giovanni-lorenzini-resolution-biosciences-sanofi-4999999/</loc>
		<lastmod>2016-09-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-allergan-plc-asahi-glass-5000034/</loc>
		<lastmod>2016-09-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-firm-twoxar-stanford-university-partner-to-identify-drug-candidates-for-hcc-4999829/</loc>
		<lastmod>2016-09-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-researchers-develop-hemaapp-to-estimate-haemoglobin-and-screen-for-anemia-5000013/</loc>
		<lastmod>2016-09-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-discovers-compounds-with-potential-to-prevent-transmission-of-malaria-5000178/</loc>
		<lastmod>2016-09-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newswho-declares-sri-lanka-malaria-free-4998264/</loc>
		<lastmod>2016-09-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-faces-american-anti-trust-probe-over-epipen-sales-contracts-4998512/</loc>
		<lastmod>2016-09-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-poll-finds-dementia-scientists-fear-loss-of-research-funding-post-brexit-4998688/</loc>
		<lastmod>2016-09-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurehow-rebuilding-entire-immune-systems-could-be-the-key-to-curing-ms-4999167/</loc>
		<lastmod>2016-09-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/changes-to-amnog-in-the-pharmaceutical-care-strengthening-act-html/</loc>
		<lastmod>2021-11-02T03:28:05+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-to-develop-vaccine-to-support-zika-response-in-us-4996838/</loc>
		<lastmod>2016-09-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newssun-pharma-forms-distribution-partnership-with-mitsubishi-tanabe-in-japan-4997107/</loc>
		<lastmod>2021-10-27T12:52:05+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-phe-reports-says-bexsero-vaccine-reduced-menb-cases-in-uk-infants-by-half-4997469/</loc>
		<lastmod>2023-06-30T06:10:10+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-amgens-sbla-for-leukemia-drug-blincyto-4996100/</loc>
		<lastmod>2016-09-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbiogens-investigational-treatment-aducanumab-secures-fda-fast-track-designation-4996101/</loc>
		<lastmod>2016-09-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuretaking-the-sting-out-of-painkillers-how-close-are-we-to-ending-the-opiate-epidemic-4996164/</loc>
		<lastmod>2016-09-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/abu-dhabi-private-health-centers-at-risk-of-closure-due-to-new-insurance-scheme-html/</loc>
		<lastmod>2021-11-02T03:28:09+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-global-diabetes-and-obesity-therapeutics-market-to-double-by-2022-4991509/</loc>
		<lastmod>2016-09-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-elite-pharmaceuticals-orexigen-therapeutics-legochem-biosciences-4994283/</loc>
		<lastmod>2016-09-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newspfizer-dcri-and-partners-collaborate-to-improve-adult-vaccination-rates-4994659/</loc>
		<lastmod>2016-09-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssunovion-to-acquire-canadas-cynapsus-therapeutics-for-624m-4995334/</loc>
		<lastmod>2016-09-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-sichuan-kelun-pharmaceutical-co-ltd-avantor-performance-materials-inc-4995475/</loc>
		<lastmod>2021-10-27T10:53:11+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-approves-genmabs-ofatumumab-for-relapsed-cll-4994223/</loc>
		<lastmod>2016-08-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsunmc-and-purdue-pharma-to-develop-drugs-for-pain-and-chronic-diseases-4994229/</loc>
		<lastmod>2016-08-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-report-says-age-general-wellbeing-can-affect-mortality-following-chemotherapy-4994406/</loc>
		<lastmod>2016-08-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureat-long-last-a-good-year-for-australias-pharma-industry-4989916/</loc>
		<lastmod>2016-08-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-to-launch-generic-epipen-to-treat-allergic-reactions-4992487/</loc>
		<lastmod>2016-08-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsredhill-biopharmas-rhb-104-gets-eu-patent-for-multiple-sclerosis-treatment-4992495/</loc>
		<lastmod>2016-08-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-approves-seqirus-influenza-vaccine-4993184/</loc>
		<lastmod>2023-05-10T05:42:54+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsaurobindo-intas-bid-for-tevas-generic-drugs-business-in-uk-4991839/</loc>
		<lastmod>2021-12-01T13:18:14+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsuk-scientists-identify-new-technique-for-early-diagnosis-of-parkinsons-disease-4991849/</loc>
		<lastmod>2016-08-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringer-and-saniona-to-develop-new-compounds-for-schizophrenia-treatment-4992148/</loc>
		<lastmod>2016-08-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-unmet-need-for-safer-anti-arrhythmic-drugs-in-the-atrial-fibrillation-market-to-continue-through-2025-4988632/</loc>
		<lastmod>2022-07-11T08:56:53+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-cell-medica-limited-cloaked-therapeutics-syncore-biotech-4988711/</loc>
		<lastmod>2016-08-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsjohns-hopkins-medicine-opens-new-zika-virus-treatment-and-research-centre-4989591/</loc>
		<lastmod>2016-08-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-ingelheim-duke-clinical-research-institute-expand-collaboration-on-ipf-study-4989652/</loc>
		<lastmod>2016-08-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-tiger-x-medical-shangai-kaibao-pharmaceutical-prometic-life-sciences-4989717/</loc>
		<lastmod>2016-08-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisais-anticancer-agent-approved-for-additional-indication-of-cll-in-japan-4990106/</loc>
		<lastmod>2016-08-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-50-4988804/</loc>
		<lastmod>2023-04-12T06:25:03+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsstudy-shows-a-new-drug-combination-slows-lung-cancer-cell-growth-4988817/</loc>
		<lastmod>2022-02-14T07:14:01+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-accepts-for-review-mylans-maa-for-proposed-biosimilar-trastuzumab-4988884/</loc>
		<lastmod>2016-08-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbarda-contracts-sab-biotherapeutics-to-advance-mers-treatment-4989051/</loc>
		<lastmod>2016-08-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurehow-the-pill-box-is-getting-smarter-4972056/</loc>
		<lastmod>2016-08-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscinven-to-acquire-us-clinical-trial-services-provider-bioclinica-in-14bn-deal-4987494/</loc>
		<lastmod>2016-08-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisai-to-launch-new-mouth-ulcer-repair-shot-in-japan-4987612/</loc>
		<lastmod>2016-08-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-to-acquire-astrazenecas-anti-infectives-business-for-15bn-4987692/</loc>
		<lastmod>2016-08-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgileads-truvada-for-hiv-1-infection-gets-ec-marketing-approval-4986383/</loc>
		<lastmod>2016-08-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslilly-and-astrazeneca-receive-fda-fast-track-designation-for-alzheimers-drug-4986398/</loc>
		<lastmod>2016-08-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-new-drug-that-melts-away-blood-cancer-for-use-in-patients-4986724/</loc>
		<lastmod>2016-08-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurexilonix-treating-cancer-in-a-new-way-4972063/</loc>
		<lastmod>2016-08-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-close-to-aquiring-medivation-for-around-14bn-4984959/</loc>
		<lastmod>2016-08-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsindia-develops-worlds-first-vaccine-for-leprosy-4985319/</loc>
		<lastmod>2016-08-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenekam-develops-therapeutic-molecule-candidate-against-zika-viruses-4985327/</loc>
		<lastmod>2016-08-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/pharma-industry-embraces-medicines-patent-pools-voluntary-licence-html/</loc>
		<lastmod>2021-11-02T03:28:13+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-turkish-pharmaceutical-industry-to-reach-55bn-in-value-by-2020-4982437/</loc>
		<lastmod>2016-08-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-pharmaceutical-secures-marketing-approval-for-cinqaero-from-european-commission-4983095/</loc>
		<lastmod>2016-08-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-omeros-corporation-cytocentrics-recro-pharma-4983626/</loc>
		<lastmod>2016-08-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-mallinckrodt-scintilla-pharmaceuticals-lonza-group-4983648/</loc>
		<lastmod>2021-10-29T08:05:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmayne-pharma-acquires-foam-assets-from-gsk-for-501m-4983817/</loc>
		<lastmod>2021-11-22T07:42:38+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuregetting-the-drugs-back-out-4972026/</loc>
		<lastmod>2016-08-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newscanadian-scientists-develop-nanorobotic-agents-to-target-cancerous-tumours-4982491/</loc>
		<lastmod>2016-08-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-court-overturns-johnson-johnsons-patent-claims-for-remicade-4982931/</loc>
		<lastmod>2016-08-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-nice-disapproves-janssens-imbruvica-for-relapsed-or-refractory-mantle-cell-lymphoma-4983105/</loc>
		<lastmod>2016-08-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsaldevron-completes-production-of-malaria-dna-vaccine-for-us-nmrc-4981411/</loc>
		<lastmod>2016-08-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-designation-to-antidepressant-medication-esketamine-4981504/</loc>
		<lastmod>2016-08-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseinstein-montefiore-and-cuny-receive-nih-grant-for-hivaids-care-in-central-africa-4981939/</loc>
		<lastmod>2016-08-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepsilocybin-vs-depression-london-study-overcomes-obstacles-to-show-encouraging-results-4939220/</loc>
		<lastmod>2016-08-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-completes-global-licence-agreement-to-tralokinumab-for-skin-diseases-4980074/</loc>
		<lastmod>2016-08-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssorrento-subsidiary-scintilla-acquires-pain-specialist-semnur-for-200m-4980186/</loc>
		<lastmod>2016-08-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfirst-dengue-immunisation-public-programme-in-americas-begins-4980438/</loc>
		<lastmod>2016-08-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/20-kilobases-closer-a-course-correction-for-molecular-diagnostics-in-germany-html/</loc>
		<lastmod>2021-11-02T03:28:16+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsvedanta-nyu-langone-to-develop-microbiome-immunotherapies-for-cancer-4977903/</loc>
		<lastmod>2016-08-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-executives-in-south-korea-face-allegations-of-illegal-rebates-4978233/</loc>
		<lastmod>2016-08-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-adverum-biotechnologies-biolinerx-ltd-zydus-cadila-4977053/</loc>
		<lastmod>2021-11-25T10:41:18+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-arterium-corporation-guanhao-biotech-4977055/</loc>
		<lastmod>2016-08-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsresearch-reveals-new-odour-baited-mosquito-traps-can-reduce-spread-of-malaria-4977085/</loc>
		<lastmod>2016-08-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscanadas-valeant-pharmaceuticals-faces-criminal-probe-for-defrauding-insurers-4977157/</loc>
		<lastmod>2016-08-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-atrial-fibrillation-market-value-to-fall-post-2022-as-patents-expire-4978052/</loc>
		<lastmod>2022-07-11T08:56:54+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjanssens-imbruvica-receives-smc-recommendation-for-blood-cancer-treatment-4975624/</loc>
		<lastmod>2016-08-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnmrc-wrair-develop-personalised-phage-cocktails-to-treat-antibiotic-resistant-infection-4975810/</loc>
		<lastmod>2016-08-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-reveals-warfarin-may-be-ineffective-for-atrial-fibrillation-over-long-term-4976737/</loc>
		<lastmod>2022-07-11T08:56:55+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurewatching-the-clock-should-day-and-night-influence-our-drug-regimens-4971648/</loc>
		<lastmod>2016-08-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshealth-canada-grants-marketing-approval-takedas-multiple-myeloma-teatment-4973969/</loc>
		<lastmod>2016-08-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshelsinn-mei-pharma-sign-deal-develop-commercialise-aml-treatment-4974497/</loc>
		<lastmod>2016-08-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-reveals-a-single-class-of-drug-could-treat-three-neglected-diseases-4975348/</loc>
		<lastmod>2016-08-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-oxitecs-gmo-mosquito-field-trials-prevent-zika-virus-4972916/</loc>
		<lastmod>2022-07-11T08:56:56+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-opdivo-receives-smc-recommendation-treat-skin-cancer-4973063/</loc>
		<lastmod>2016-08-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newscrt-birmingham-university-alta-collaborate-commercialise-cancer-research-4973758/</loc>
		<lastmod>2016-08-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurejulys-top-stories-cancer-drugs-fund-implemented-uk-nichi-iko-acquired-sagent-pharmaceuticals-4967468/</loc>
		<lastmod>2021-11-30T11:31:27+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuretackling-counterfeit-viagra-4970635/</loc>
		<lastmod>2016-08-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/comment/commentcould-copper-unlock-a-new-wave-of-metabolic-treatments-4971352/</loc>
		<lastmod>2016-08-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsidt-donates-reagents-support-eliminate-dengue-brazils-research-control-zika-virus-4971423/</loc>
		<lastmod>2016-08-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsscinopharm-cvie-develop-new-heart-failure-treatment-4971746/</loc>
		<lastmod>2016-08-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-reveals-alcohol-abuse-control-drug-treat-blinding-disorder-4972492/</loc>
		<lastmod>2016-08-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsreport-pharmaceutical-industry-pipeline-dominated-top-three-therapy-areas-q1-2016-4968190/</loc>
		<lastmod>2016-08-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-orgenesis-advanced-accelerator-applications-kyowa-pharmaceutical-4970027/</loc>
		<lastmod>2023-05-15T03:55:48+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-teva-pharmaceutical-industries-ltd-epic-health-services-4970047/</loc>
		<lastmod>2016-08-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-lee011-breast-cancer-treatment-receives-fda-breakthrough-therapy-designation-4970050/</loc>
		<lastmod>2016-08-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsgenetic-testing-rare-form-tumour-reveal-cancer-chances-families-4970173/</loc>
		<lastmod>2016-08-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisais-thyroid-cancer-treatment-included-cdf-evaluation-nice-4968559/</loc>
		<lastmod>2016-08-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsaustralian-state-victoria-signs-two-agreements-improve-healthcare-cancer-treatment-4968646/</loc>
		<lastmod>2016-08-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-acquire-allergans-generic-pharmaceuticals-distribution-business-anda-500m-4969668/</loc>
		<lastmod>2016-08-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/comment/commentlupus-breakthrough-sparks-hope-in-a-frustrating-field-4951550/</loc>
		<lastmod>2016-08-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-chi-med-amend-agreement-savolitinib-treat-several-cancers-4966666/</loc>
		<lastmod>2016-08-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsuk-high-court-judicial-review-rules-nhs-fund-hiv-prevention-drug-4967365/</loc>
		<lastmod>2016-08-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsanthrax-outbreak-remote-russia-kills-one-hospitalises-nearly-90-people-4968036/</loc>
		<lastmod>2016-08-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-janssen-sign-licence-agreement-cnto-7160-asthma-treatment-worldwide-4966023/</loc>
		<lastmod>2016-08-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsshires-shp626-fda-fast-track-designation-nash-liver-fibrosis-4966040/</loc>
		<lastmod>2016-08-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsibm-team-develops-new-lab-on-a-chip-technology-physicians-detect-cancer-4966637/</loc>
		<lastmod>2016-08-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/new-zealands-pharmac-finally-reimburses-keytruda-to-cancer-groups-delight-and-disgust-html/</loc>
		<lastmod>2021-11-02T03:28:20+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsis-the-uk-education-system-meeting-the-needs-of-pharma-companies-4950447/</loc>
		<lastmod>2016-07-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-sanofis-adlyxin-injection-type-ii-diabetes-4964036/</loc>
		<lastmod>2016-07-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newssingapore-scientists-research-mini-midbrains-develop-new-treatments-4964238/</loc>
		<lastmod>2016-07-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newschinese-company-fosun-acquires-majority-stake-gland-pharma-126bn-4965541/</loc>
		<lastmod>2016-07-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-vietnams-pharmaceutical-market-robust-growth-cagr-13-8-4962319/</loc>
		<lastmod>2022-04-05T09:03:57+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-protrials-research-inc-bristol-myers-squibb-espada-dermatology-4962923/</loc>
		<lastmod>2021-11-26T05:33:32+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-relief-therapeutics-china-resources-sanjiu-medical-4962936/</loc>
		<lastmod>2021-10-29T05:20:51+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-cancer-drugs-fund-comes-into-effect-uk-4963354/</loc>
		<lastmod>2016-07-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsroche-demands-urgent-re-assessment-cancer-drug-approvals-uk-4963408/</loc>
		<lastmod>2016-07-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/cutaneous-leishmaniasis-sweeps-across-middle-east-html/</loc>
		<lastmod>2021-11-02T03:28:25+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-releases-sanofis-influenza-vaccine-shipment-4961936/</loc>
		<lastmod>2016-07-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-invest-275m-three-drug-manufacturing-sites-uk-4962329/</loc>
		<lastmod>2016-07-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmsd-launches-duavive-uk-treat-oestrogen-deficiency-symptoms-postmenopausal-women-4962427/</loc>
		<lastmod>2022-12-02T15:19:24+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsprokarium-receives-government-funding-develop-three-new-vaccines-4960102/</loc>
		<lastmod>2023-05-29T05:29:32+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsemas-chmp-grants-positive-opinion-allergans-ibs-d-treatment-europe-4960281/</loc>
		<lastmod>2016-07-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-reveals-eczema-patients-colonised-s-aureus-4961213/</loc>
		<lastmod>2022-07-11T08:56:57+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-drug-company-tackling-disease-in-lebanons-packed-refugee-camps-4939176/</loc>
		<lastmod>2016-07-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-qidp-fast-track-designation-morphochems-cdi-treatment-4958936/</loc>
		<lastmod>2016-07-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsuniversity-leicester-researchers-reveal-positive-impact-pokmon-go-obesity-4959012/</loc>
		<lastmod>2016-07-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-cancer-research-uk-study-reveals-anti-malaria-drug-support-cancer-treatment-4959565/</loc>
		<lastmod>2016-07-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurenurturing-an-african-pharma-boom-4960692/</loc>
		<lastmod>2016-07-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsicr-royal-marsden-researchers-develop-anti-evolution-cancer-therapies-4957386/</loc>
		<lastmod>2016-07-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-biocon-receive-maa-review-acceptance-ema-pegfilgrastim-4957524/</loc>
		<lastmod>2016-07-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-chmp-receives-positive-opinion-eisais-combination-treatment-rcc-4958468/</loc>
		<lastmod>2016-07-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-significant-growth-forecasted-saudi-pharmaceutical-market-4955702/</loc>
		<lastmod>2016-07-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsec-awards-grant-commercialise-latimas-cancer-virotherapy-medicine-4956111/</loc>
		<lastmod>2016-07-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-centre-drug-research-development-taizhou-institute-health-sciences-fudan-university-teva-pharmaceuticals-4956116/</loc>
		<lastmod>2016-07-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabcellera-massbiologics-collaborate-prevent-multidrug-resistant-bacteria-4956769/</loc>
		<lastmod>2023-06-12T04:10:32+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-hansa-medical-knight-therapeutics-4957335/</loc>
		<lastmod>2016-07-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsresearch-shows-early-art-hiv-patients-reduces-heterosexual-transmission-4955374/</loc>
		<lastmod>2016-07-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslumi-kantar-health-receive-mrmw-award-new-mobile-health-survey-app-4955453/</loc>
		<lastmod>2016-07-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-nice-issues-final-guidance-recommending-translarna-treat-nmdmd-patients-4955710/</loc>
		<lastmod>2016-07-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-49-4955495/</loc>
		<lastmod>2023-04-12T06:25:38+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-cambridge-consultants-creates-new-spin-out-promote-dna-synthesis-4953848/</loc>
		<lastmod>2016-07-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-eisais-belviq-xr-chronic-weight-management-4954583/</loc>
		<lastmod>2016-07-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscdrd-astrazeneca-develop-new-drug-therapies-diseases-unmet-medical-need-4954680/</loc>
		<lastmod>2016-07-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/brexit-impact-on-healthcare-a-lot-of-cloud-and-no-silver-lining-html/</loc>
		<lastmod>2021-11-02T03:28:30+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnih-study-finds-high-levels-urinary-paracetamol-may-affect-male-fertility-4952669/</loc>
		<lastmod>2016-07-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-accepts-maa-review-mercks-relapsing-multiple-sclerosis-treatment-4952707/</loc>
		<lastmod>2016-07-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-proton-partners-receives-investment-develop-northumberland-cancer-centre-4953138/</loc>
		<lastmod>2016-07-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/inaction-on-hospital-drug-spending-ruffles-ec-feathers-as-fresh-political-deadlock-likely-in-spain-html/</loc>
		<lastmod>2021-11-02T03:15:37+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringer-ingelheim-dundee-university-partner-develop-protac-based-drugs-4951436/</loc>
		<lastmod>2016-07-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjuno-therapeutics-acquires-redoxtherapies-vipadenant-licence-us-4951495/</loc>
		<lastmod>2016-07-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssingapore-astars-gis-researchers-new-pathways-leading-cancer-progression-4952087/</loc>
		<lastmod>2023-03-10T05:41:13+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-cantabio-pharma-roivant-sciences-cypralis-limited-4949822/</loc>
		<lastmod>2016-07-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-epiva-biosciences-ningbo-medical-system-biotechnology-martindale-pharmaceuticals-4949842/</loc>
		<lastmod>2016-07-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-pricing-take-precedence-pharmaceutical-companies-strive-remain-profitable-mature-type-2-diabetes-market-4950212/</loc>
		<lastmod>2016-07-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshealth-canada-initiates-approval-application-review-sobis-ht-1-treatment-4950252/</loc>
		<lastmod>2016-07-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsqueens-university-research-reveals-new-way-treating-fibromyalgia-4950306/</loc>
		<lastmod>2016-07-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-nice-sepsis-trust-partner-improve-sepsis-treatment-across-nhs-4948867/</loc>
		<lastmod>2016-07-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsredhill-biopharma-niaid-partner-research-ebola-virus-treatment-4949395/</loc>
		<lastmod>2016-07-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-signs-agreement-commercialise-amgens-biosimilars-japan-4949458/</loc>
		<lastmod>2016-07-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureblueberries-from-superfood-to-a-potential-ptsd-treatment-4913095/</loc>
		<lastmod>2016-07-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-peakdale-signs-agreement-centauri-alphamer-technology-development-4946776/</loc>
		<lastmod>2016-07-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjapans-nichi-iko-acquire-sagent-pharmaceuticals-nearly-736m-4947394/</loc>
		<lastmod>2016-07-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-approval-pfizers-prevnar-13-prevent-pneumococcal-pneumonia-4948111/</loc>
		<lastmod>2016-07-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscipla-invest-south-africas-first-biosimilars-production-facility-4945516/</loc>
		<lastmod>2016-07-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsscientists-develop-new-telephone-based-dengue-fever-forecast-system-4945659/</loc>
		<lastmod>2016-07-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newssingapores-astar-gis-researchers-track-treat-lung-cancer-patients-4946681/</loc>
		<lastmod>2022-07-11T08:56:57+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/sweden-denmark-and-italy-offer-to-host-ema-headquarters-in-the-event-relocation-is-necessary-html/</loc>
		<lastmod>2021-11-02T03:18:17+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsadalta-announces-ipo-fund-clinical-studies-new-fibrosis-therapy-4944520/</loc>
		<lastmod>2016-07-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-international-project-launched-develop-cancer-cell-culture-models-4944606/</loc>
		<lastmod>2016-07-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenentechs-xolair-receives-us-fda-approval-allergic-asthma-treatment-4945264/</loc>
		<lastmod>2023-01-19T06:40:55+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/latin-america-the-going-gets-tough-html/</loc>
		<lastmod>2021-11-02T03:18:20+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-urological-cancers-market-grow-10-39-reach-35-9bn-2022-4942374/</loc>
		<lastmod>2016-07-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-takeda-pharma-mesoblast-limited-aslan-pharmaceuticals-4942892/</loc>
		<lastmod>2023-05-29T05:37:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-nantong-jinghua-pharma-accuron-technologies-4942920/</loc>
		<lastmod>2016-07-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-wrair-sign-research-agreement-co-develop-zika-vaccine-candidate-4943192/</loc>
		<lastmod>2016-07-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newszydus-mpp-sign-sub-licence-agreement-bristol-myers-hepatitis-medicine-4943317/</loc>
		<lastmod>2017-09-29T04:07:19+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/featurebenign-by-design-the-long-road-to-biodegradable-drugs-4913115/</loc>
		<lastmod>2017-09-29T04:07:24+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-tigenix-sign-cx601s-ex-us-licence-agreement-perianal-fistulas-crohns-disease-4941855/</loc>
		<lastmod>2016-07-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsredhill-intelgenx-grupo-juste-sign-licence-agreement-market-rizaport-spain-4941944/</loc>
		<lastmod>2016-07-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbiogen-abbvie-receive-ema-approval-marketing-daclizumab-uk-4942332/</loc>
		<lastmod>2016-07-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/liquid-biopsies-the-next-wave-of-cancer-screening-html/</loc>
		<lastmod>2021-11-02T03:18:23+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurenew-frontiers-outsourcing-clinical-trials-in-emerging-markets-4939225/</loc>
		<lastmod>2022-07-11T08:56:58+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsregeneron-sanofi-receive-approval-praluent-treat-hypercholesterolemia-japan-4941082/</loc>
		<lastmod>2023-04-14T07:58:52+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-nice-denies-use-bristol-myers-nivolumab-treat-kidney-cancer-4941198/</loc>
		<lastmod>2016-07-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurejunes-top-stories-thailand-free-mother-child-hiv-transmission-jazz-pharmaceuticals-acquired-celator-4942069/</loc>
		<lastmod>2016-07-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsicr-researchers-find-new-genetic-variations-linked-myeloma-risk-4940289/</loc>
		<lastmod>2016-07-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsallergans-belkyra-receives-positive-opinion-swedish-mpa-treat-double-chin-4940412/</loc>
		<lastmod>2016-07-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-develops-harmless-e-coli-based-transport-capsule-pneumococcal-disease-4940846/</loc>
		<lastmod>2016-07-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsprobiodrug-crossbeta-partner-alzheimers-biomarker-development-activities-4938998/</loc>
		<lastmod>2016-07-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmundipharma-orexo-launch-opioid-dependence-treatment-zubsolv-outside-us-4939014/</loc>
		<lastmod>2016-07-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureantibiotic-resistance-could-rapid-tests-prevent-disaster-4939214/</loc>
		<lastmod>2016-07-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsferring-receives-nice-recommendation-firmagon-uk-4939805/</loc>
		<lastmod>2016-07-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-merck-gain-from-entering-idiopathic-pulmonary-fibrosis-market-4935870/</loc>
		<lastmod>2021-12-01T12:31:14+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-liquid-biotech-entourage-phytolab-mayne-pharma-4937613/</loc>
		<lastmod>2021-11-22T07:43:28+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvie-janssen-receive-fourth-fda-breakthrough-therapy-designation-imbruvica-4937785/</loc>
		<lastmod>2016-06-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsviiv-healthcare-penta-partner-develop-treatment-strategies-children-hiv-4938066/</loc>
		<lastmod>2016-06-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-tbg-diagnostics-charles-river-4938973/</loc>
		<lastmod>2016-06-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/launch-in-the-time-of-cost-containment-how-are-european-countries-positioned-to-fund-emerging-breakthroughs-in-oncology-html/</loc>
		<lastmod>2021-11-02T03:18:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgileads-epclusa-receives-fda-approval-treat-genotype-i-vi-chronic-hcv-4936474/</loc>
		<lastmod>2016-06-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-loulou-foundation-odc-award-11-research-grants-cdkl5-deficiency-4936580/</loc>
		<lastmod>2016-06-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newscanadian-researchers-create-protein-signatures-diagnose-prostate-cancer-4937508/</loc>
		<lastmod>2016-06-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureof-mice-and-men-debating-animal-research-in-drug-development-4938505/</loc>
		<lastmod>2020-01-31T13:46:12+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenentech-fda-review-acceptance-ocrevus-biologics-licence-application-4935341/</loc>
		<lastmod>2016-06-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-invest-new-global-biotechnology-centre-china-4935454/</loc>
		<lastmod>2021-11-22T10:30:48+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsxbiotech-megapharm-sign-agreement-commercialise-xilonix-israel-4936141/</loc>
		<lastmod>2016-06-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuretookad-soluble-a-revolution-in-prostate-cancer-treatment-4913085/</loc>
		<lastmod>2016-06-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-boehringer-ingelheim-sign-contract-25bn-business-swap-4933572/</loc>
		<lastmod>2016-06-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsswissmedic-grants-approval-sobis-elocta-treat-haemophilia-a-4933630/</loc>
		<lastmod>2016-06-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newschmp-grants-positive-opinion-recommending-mercks-keytruda-treat-nsclc-4934577/</loc>
		<lastmod>2016-06-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-48-4933581/</loc>
		<lastmod>2023-04-21T09:47:23+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/colombias-moh-vs-novartis-v2-html/</loc>
		<lastmod>2021-11-02T03:18:30+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-releases-acd-not-recommend-astrazenecas-tagrisso-nsclc-treatment-4932763/</loc>
		<lastmod>2016-06-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-chmp-issues-positive-opinion-tevas-cinqaero-4933189/</loc>
		<lastmod>2016-06-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsema-recommends-zalmoxis-support-stem-cell-transplantation-patients-high-risk-blood-cancer-4933258/</loc>
		<lastmod>2022-07-11T08:56:59+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-licensing-deal-values-in-the-pharmaceutical-industry-surged-in-2015-led-by-sanofi-4929545/</loc>
		<lastmod>2021-12-02T09:25:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-savara-pharma-xiangxue-pharmaceuticals-4931040/</loc>
		<lastmod>2016-06-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsscientists-reveal-hops-extract-could-help-reduce-breast-cancer-4931389/</loc>
		<lastmod>2016-06-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspaxvax-receives-acip-recommendation-for-vaxchora-cholera-vaccine-4932140/</loc>
		<lastmod>2016-06-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurea-new-hope-for-heroin-addiction-4912998/</loc>
		<lastmod>2016-06-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnew-report-says-leukaemia-have-largest-active-development-pipeline-4930170/</loc>
		<lastmod>2016-06-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsorion-and-asahi-kasei-enter-collaboration-agreement-pain-management-assets-4930853/</loc>
		<lastmod>2016-06-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-ogd2-pharma-orig3n-impax-labs-4931008/</loc>
		<lastmod>2016-06-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnih-fiocruz-conduct-study-assess-effect-zika-virus-pregnant-women-4931200/</loc>
		<lastmod>2016-06-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureinformation-overload-using-text-mining-to-open-up-clinical-research-4893227/</loc>
		<lastmod>2016-06-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvie-eisai-ea-pharma-receive-additional-approval-new-humira-dosing-regimen-4928706/</loc>
		<lastmod>2016-06-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-nhrc-commences-clinical-trial-norovirus-vaccine-rtc-4928768/</loc>
		<lastmod>2022-12-07T14:21:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-nice-grants-technology-appraisal-guidance-sanofis-praluent-alirocumab-4929822/</loc>
		<lastmod>2016-06-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsindian-firm-zydus-cadila-purchases-two-andas-teva-4927511/</loc>
		<lastmod>2016-06-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsf2g-raises-60m-financing-develop-invasive-fungal-infections-therapies-4927566/</loc>
		<lastmod>2023-05-30T04:21:07+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-finds-20-dose-course-prostate-cancer-radiotherapy-reduces-hospital-visits-uk-4928236/</loc>
		<lastmod>2016-06-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/a-vote-to-leave-the-european-union-and-what-it-would-mean-for-britains-place-in-the-world-of-pharma-html/</loc>
		<lastmod>2021-11-02T03:18:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-analysis-reveals-brexit-would-affect-uk-pharmaceutical-industry-4925062/</loc>
		<lastmod>2016-06-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-issues-final-appraisal-determination-vertexs-orkambi-treat-cystic-fibrosis-4926780/</loc>
		<lastmod>2016-06-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsshield-therapeutics-launches-feraccru-treat-ida-ibd-patients-uk-4927390/</loc>
		<lastmod>2016-06-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/budget-impact-in-france-a-new-key-to-market-access-html/</loc>
		<lastmod>2021-11-02T03:18:36+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-organovo-thermo-fisher-scientific-immunogen-4924581/</loc>
		<lastmod>2016-06-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-trelleborg-polpharma-4924616/</loc>
		<lastmod>2016-06-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsindias-zydus-cadila-eczacba-market-biotech-products-turkey-4924805/</loc>
		<lastmod>2022-03-29T11:53:08+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-rapid-growth-global-type-2-diabetes-market-fuelled-rising-incidence-disease-4925007/</loc>
		<lastmod>2023-05-22T08:39:58+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-biotechnology-firm-illumina-signs-deals-provide-gsa-samples-12-customers-4925914/</loc>
		<lastmod>2016-06-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuresaving-lives-through-the-supply-chain-4893013/</loc>
		<lastmod>2022-07-11T08:57:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnih-funded-study-finds-proper-maternal-folate-levels-reduce-childhood-obesity-4923715/</loc>
		<lastmod>2016-06-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-data-finds-middle-aged-people-more-likely-diagnosed-advanced-lung-cancer-4923841/</loc>
		<lastmod>2016-06-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-discover-heart-drug-darapladibm-reduce-diabetes-related-blindness-4924640/</loc>
		<lastmod>2016-06-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureolive-leaf-extract-on-trial-4892606/</loc>
		<lastmod>2022-07-11T08:57:01+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-survey-reveals-uk-failing-meet-european-standards-lung-cancer-treatment-4921898/</loc>
		<lastmod>2016-06-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscharleston-laboratories-daiichi-sankyos-nda-cl-108-receives-fda-acceptance-4921986/</loc>
		<lastmod>2016-06-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-designation-shires-shp621-shp625-4922984/</loc>
		<lastmod>2016-06-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/nices-proposed-abbreviated-technology-appraisal-scheme-html/</loc>
		<lastmod>2021-11-02T03:18:41+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspaxvax-receives-us-marketing-approval-fda-cholera-vaccine-4921038/</loc>
		<lastmod>2016-06-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsfda-legal-action-against-4402-unlawful-drug-selling-websites-4921120/</loc>
		<lastmod>2016-06-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-wrair-beth-israel-deaconess-conduct-preclinical-research-zika-vaccine-candidate-4921769/</loc>
		<lastmod>2016-06-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuremoving-on-up-could-clinical-trial-data-go-mobile-4872520/</loc>
		<lastmod>2016-06-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsaspen-acquire-commercialisation-rights-astrazenecas-anaesthetics-outside-us-4919717/</loc>
		<lastmod>2016-06-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newscannabis-serves-orphan-drug-several-rare-medical-conditions-4920140/</loc>
		<lastmod>2016-06-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsviiv-healthcare-receives-fda-approval-dolutegravir-lower-weight-hiv-i-patients-4920500/</loc>
		<lastmod>2016-06-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/greek-pharma-industry-unites-against-growing-burden-of-clawback-html/</loc>
		<lastmod>2021-11-02T03:18:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-crisaborole-benefit-merger-between-pfizer-anacor-4916992/</loc>
		<lastmod>2016-06-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-takeda-pharma-cellectrion-ab-vascular-biogenics-4918045/</loc>
		<lastmod>2016-06-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-ldc-jss-medical-research-4918076/</loc>
		<lastmod>2016-06-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-signs-definitive-agreement-to-buy-us-firm-afferent-pharmaceuticals-4919132/</loc>
		<lastmod>2016-06-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsthailand-certified-to-be-free-of-mother-to-child-hiv-transmission-4919292/</loc>
		<lastmod>2016-06-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurescaling-up-the-pharma-sectors-smart-packaging-revolution-4872817/</loc>
		<lastmod>2016-06-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newscancer-research-uk-develop-new-bubbly-drink-effective-cancer-treatment-4917824/</loc>
		<lastmod>2016-06-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-signs-licensing-deal-theravances-td-8954-treat-gastrointestinal-motility-disorders-4917925/</loc>
		<lastmod>2021-11-25T10:49:09+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-thrombogenics-ocriplasmin-to-treat-vitreomacular-adhesion-4918419/</loc>
		<lastmod>2022-10-03T12:51:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsten-companies-join-ghit-fund-expand-rd-investments-neglected-diseases-4916411/</loc>
		<lastmod>2016-06-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstexas-am-university-system-ibio-develop-plant-produced-pharmaceuticals-4916561/</loc>
		<lastmod>2016-06-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslucideon-skyepharma-develop-icrt-deter-abuse-deterrent-4917003/</loc>
		<lastmod>2016-06-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurea-pharma-perspective-on-the-uks-rd-tax-credit-scheme-4893137/</loc>
		<lastmod>2016-06-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuremays-top-stories-abbvie-take-over-stemcentrx-bayer-acquire-monsanto-4907625/</loc>
		<lastmod>2016-06-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-approves-novimmunes-ni-0501-eligible-prime-scheme-europe-4915044/</loc>
		<lastmod>2016-06-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbio-products-laboratory-makes-coagadex-available-uk-rare-bleeding-disorder-4915134/</loc>
		<lastmod>2016-06-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenentech-osi-pay-67m-resolve-false-claims-act-allegations-tarceva-4915552/</loc>
		<lastmod>2016-06-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovavax-presents-data-developing-seasonal-influenza-nanoparticles-rsv-4913469/</loc>
		<lastmod>2016-06-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-eisai-promote-lenvima-combination-everolimus-treat-rcc-4913713/</loc>
		<lastmod>2016-06-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbellicum-lumc-collaborate-discover-tcrs-treat-several-cancers-4914140/</loc>
		<lastmod>2016-06-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-incyte-sandoz-ag-mylan-nv-4911437/</loc>
		<lastmod>2021-10-29T05:20:55+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-biomerieux-recordati-4911461/</loc>
		<lastmod>2021-12-02T12:17:51+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-invasive-meningococcal-cases-set-decrease-rate-237-per-year-4911464/</loc>
		<lastmod>2016-06-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-genetic-approach-could-reduce-risk-late-stage-drug-failures-4912634/</loc>
		<lastmod>2016-06-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvie-ea-pharma-co-promote-humira-gastrointestinal-diseases-4912664/</loc>
		<lastmod>2016-06-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurerussia-a-bright-future-for-clinical-trials-4872809/</loc>
		<lastmod>2022-07-11T08:57:02+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsrecordati-takes-italian-pharmaceutical-company-italchimici-130m-4910731/</loc>
		<lastmod>2021-12-02T12:16:50+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjanssen-cilag-receives-ec-approval-trevicta-maintenance-treatment-schizophrenia-4910758/</loc>
		<lastmod>2016-06-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsviiv-healthcare-iapac-partner-focus-16-hiv-prevalent-fast-track-cities-4911419/</loc>
		<lastmod>2016-06-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurewhen-drug-trials-turn-tragic-learning-from-rennes-4872821/</loc>
		<lastmod>2022-07-11T08:57:03+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsirelands-jazz-pharmaceuticals-acquire-us-firm-celator-nearly-1-5bn-4909533/</loc>
		<lastmod>2016-05-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsec-grants-approval-amicuss-galafold-treat-fabry-disease-4909586/</loc>
		<lastmod>2023-05-22T07:18:15+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsroches-mabthera-sc-receives-ec-approval-treat-chronic-lymphocytic-leukaemia-4909820/</loc>
		<lastmod>2016-05-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepregnancy-and-childbirth-where-are-the-new-drugs-4872633/</loc>
		<lastmod>2016-05-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsema-recommends-marketing-authorisations-epclusa-zepatier-treat-hepatitis-c-virus-4907869/</loc>
		<lastmod>2016-05-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssamsung-bioepis-secures-ec-approval-market-ra-biosimilar-flixabi-eu-4908395/</loc>
		<lastmod>2016-05-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsinserm-researchers-develop-new-drugs-treat-skin-cancer-4908929/</loc>
		<lastmod>2016-05-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-cell-therapy-catapult-evercyte-thunderbolt-pharma-4904772/</loc>
		<lastmod>2016-05-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-biodel-dirui-industrial-therametrics-4904797/</loc>
		<lastmod>2021-12-07T08:09:07+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-grants-fast-track-designation-novavaxs-rsv-f-vaccine-4905315/</loc>
		<lastmod>2016-05-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fdas-emdac-recommends-approval-sanofis-nda-treat-type-ii-diabetes-4905328/</loc>
		<lastmod>2016-05-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscsl-behring-receives-fda-approval-treat-haemophilia-a-4905793/</loc>
		<lastmod>2016-05-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/whos-paying-for-precision-medicine-a-look-at-molecular-diagnostic-commissioning-policy-in-the-uk-html/</loc>
		<lastmod>2021-11-02T03:19:04+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-breast-cancer-drug-pipeline-pharmas-biggest-success-story-4893023/</loc>
		<lastmod>2016-05-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-crt-pangaea-biotech-develop-new-drugs-treat-cancer-4904822/</loc>
		<lastmod>2016-05-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newszambon-introduces-xadago-uk-treat-parkinsons-disease-4904853/</loc>
		<lastmod>2016-05-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-nice-recommends-sanofis-jevtana-treat-advanced-prostate-cancer-4904888/</loc>
		<lastmod>2016-05-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastellas-daiichi-sankyo-takeda-analyse-biomarker-data-healthy-adults-4903438/</loc>
		<lastmod>2016-05-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsec-grants-conditional-approval-janssens-darzalex-treat-multiple-myeloma-4903500/</loc>
		<lastmod>2016-05-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdefence-committee-anti-malarial-drug-lariam-drug-last-resort-troops-4903595/</loc>
		<lastmod>2016-05-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-review-pfizers-maa-meningococcal-group-vaccine-4902093/</loc>
		<lastmod>2016-05-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnew-initiative-deliver-potential-life-saving-drugs-uk-cancer-patients-sooner-4902118/</loc>
		<lastmod>2016-05-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbayer-enter-chemicals-industry-62bn-acquisition-monsanto-4902319/</loc>
		<lastmod>2016-05-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/from-tiered-pricing-to-tiered-ip-the-evolving-access-to-medicines-landscape-html/</loc>
		<lastmod>2021-11-02T03:19:07+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-establishes-new-global-clinical-programme-entresto-heart-failure-4900502/</loc>
		<lastmod>2016-05-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshorizon-pharma-acquire-rights-interferon-gamma-1b-boehringer-4900720/</loc>
		<lastmod>2016-05-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbiopharma-services-conduct-in-vivo-studies-generic-drug-products-4900916/</loc>
		<lastmod>2016-05-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-week-trianni-ani-pharma-merus-labs-4897750/</loc>
		<lastmod>2016-05-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-strides-shasun-shanghai-fosun-pharma-4898070/</loc>
		<lastmod>2021-10-27T12:47:57+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscgt-aberdeen-university-establishes-new-company-diabetes-treatment-4898822/</loc>
		<lastmod>2016-05-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-psoriasis-market-double-2024-4899087/</loc>
		<lastmod>2016-05-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsroche-receives-fda-approval-tecentriq-treat-urothelial-carcinoma-4899093/</loc>
		<lastmod>2016-05-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-status-celators-vyxeos-treat-aml-4899161/</loc>
		<lastmod>2016-05-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssouth-korea-approves-boehringers-lung-cancer-drug-olmutinib-4898235/</loc>
		<lastmod>2016-05-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmacrogenics-enters-agreement-janssen-develop-mgd015-4898280/</loc>
		<lastmod>2016-05-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsfda-takes-measures-prevent-marketing-illegal-fluoride-supplements-4898396/</loc>
		<lastmod>2016-05-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-47-4897334/</loc>
		<lastmod>2023-04-12T06:24:12+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/access-our-insights-life-sciences-mcs-content-now-available-on-the-ihs-online-store-html/</loc>
		<lastmod>2021-11-02T03:19:10+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-in-israel-building-a-global-industry-4866023/</loc>
		<lastmod>2021-11-22T08:01:41+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-designation-vm202-treat-patients-als-4896908/</loc>
		<lastmod>2016-05-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-mission-pharmacals-usp-oral-solution-prevent-thyroid-cancer-4896916/</loc>
		<lastmod>2016-05-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-opens-280m-expanded-biologics-facility-massachusetts-4897208/</loc>
		<lastmod>2016-05-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuregut-bacteria-manipulating-the-microbiome-4872437/</loc>
		<lastmod>2016-05-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-to-acquire-topicals-business-from-renaissance-for-950m-4895399/</loc>
		<lastmod>2016-05-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisais-lenvima-receives-fda-approval-for-new-indication-4895487/</loc>
		<lastmod>2016-05-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-acquire-anacor-pharmaceuticals-5-2bn-4895710/</loc>
		<lastmod>2016-05-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newswho-afro-collaborates-ifpma-prevent-cervical-cancer-africa-4893168/</loc>
		<lastmod>2016-05-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastars-gis-researchers-develop-new-technique-understand-rna-network-4894072/</loc>
		<lastmod>2016-05-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnew-research-suggests-high-levels-of-folate-in-pregnant-women-increases-autism-risk-4894635/</loc>
		<lastmod>2023-05-29T06:43:59+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-heart-failure-market-witness-compound-annual-growth-rate-13-7-4889663/</loc>
		<lastmod>2016-05-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-week-daiichi-sankyo-trianni-aptinyx-4891374/</loc>
		<lastmod>2016-05-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-sygnis-incyte-aptuit-4891391/</loc>
		<lastmod>2016-05-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newscancer-research-uk-invests-studying-cancers-low-survival-rates-4891666/</loc>
		<lastmod>2016-05-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-designation-astrazenecas-selumetinib-thyroid-cancer-4892283/</loc>
		<lastmod>2016-05-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurenature-provides-bioprospecting-for-new-blockbuster-drugs-4867033/</loc>
		<lastmod>2016-05-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureencouraging-innovation-in-pharma-manufacturing-4872321/</loc>
		<lastmod>2016-05-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-approves-gsks-lupus-drug-benlysta-4889836/</loc>
		<lastmod>2016-05-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsldc-boehringer-max-planck-partner-discover-treatment-schizophrenia-4891315/</loc>
		<lastmod>2016-05-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-nice-rejects-use-nivolumab-treat-nsclc-4891344/</loc>
		<lastmod>2016-05-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbiopharmx-research-molecular-iodine-restore-normal-breast-tissue-4888395/</loc>
		<lastmod>2016-05-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscell-therapy-grants-japanese-licence-heartcel-daiichi-sankyo-4888667/</loc>
		<lastmod>2016-05-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsoxford-spinout-vaccitech-develop-universal-flu-vaccine-4889282/</loc>
		<lastmod>2016-05-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-develop-new-antibody-based-drug-treat-hiv-4886948/</loc>
		<lastmod>2016-05-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsresearch-reveals-female-sex-hormone-prevent-sexually-transmitted-infections-4887194/</loc>
		<lastmod>2016-05-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdrones-supply-life-saving-drugs-africa-4888161/</loc>
		<lastmod>2022-02-03T02:16:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-nice-recommends-humira-treatment-hidradenitis-suppurativa-4886166/</loc>
		<lastmod>2016-05-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsniams-researchers-find-ilcs-respond-quickly-infection-4886725/</loc>
		<lastmod>2016-05-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsmit-researchers-develop-new-paper-based-test-to-diagnose-zika-virus-4886760/</loc>
		<lastmod>2016-05-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-uncertain-economic-environment-affect-italys-pharmaceutical-industry-4881608/</loc>
		<lastmod>2016-05-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-week-foundation-medicine-marina-biotech-viamet-pharma-4884601/</loc>
		<lastmod>2016-05-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-precision-medicine-veristat-4884648/</loc>
		<lastmod>2016-05-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-recommends-sanofis-praluent-effective-treatment-bad-cholesterol-4885336/</loc>
		<lastmod>2016-05-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseli-lilly-receives-fda-priority-review-approval-olaratumab-4885383/</loc>
		<lastmod>2016-05-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuregroundbreaking-medicine-tthe-t-cell-revolution-4872225/</loc>
		<lastmod>2016-05-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureaprils-top-stories-nhs-england-reconsidered-decision-prep-mismanagement-dementia-cost-1bn-annually-4879925/</loc>
		<lastmod>2016-05-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbiogens-daclizumab-receives-positive-opinion-treat-multiple-sclerosis-4883284/</loc>
		<lastmod>2016-05-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsuk-crt-pioneer-fund-invests-develop-hsf1-drugs-cancer-4883334/</loc>
		<lastmod>2016-05-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-polyphotonix-launches-sleep-mask-treat-diabetic-retinopathy-4884331/</loc>
		<lastmod>2023-01-23T13:37:06+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureobamas-1-billion-moonshot-is-curing-cancer-realistic-4872619/</loc>
		<lastmod>2016-05-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-recommends-zavicefta-treat-multi-drug-resistant-bacteria-eu-4882175/</loc>
		<lastmod>2016-05-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsroches-gazyvaro-ema-recommendation-treat-rare-white-blood-cell-cancer-4882303/</loc>
		<lastmod>2016-05-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-studies-show-cannabis-specifically-targets-cancer-without-harming-healthy-cells-4882816/</loc>
		<lastmod>2016-05-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvie-take-over-stemcentrx-rova-t-therapy-sclc-5-8bn-4880608/</loc>
		<lastmod>2016-05-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsallergan-receives-marketing-authorisation-enzepi-4881539/</loc>
		<lastmod>2016-05-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-researchers-investigate-gene-therapy-treatment-x-linked-retinitis-pigmentosa-4881546/</loc>
		<lastmod>2016-05-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-use-of-orfadin-oral-suspension-to-treat-hereditary-tyrosinemia-type-1-4877751/</loc>
		<lastmod>2016-04-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-lexogen-perkinelmer-interprotein-hainan-haiyao-novacyt-flx-bio-4877922/</loc>
		<lastmod>2016-04-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-johnson-johnson-dna20-4877952/</loc>
		<lastmod>2016-04-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreport-policy-initiatives-focus-generics-drive-south-korean-pharmaceutical-market-growth-4878621/</loc>
		<lastmod>2022-01-19T13:43:45+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsastrazenecas-lynparza-available-for-brcam-ovarian-cancer-patients-in-nhs-england-and-wales-4878666/</loc>
		<lastmod>2016-04-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newszymeworks-partners-gsk-develop-bi-specific-antibodies-4876738/</loc>
		<lastmod>2021-11-25T09:48:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsqueens-university-domainex-receive-late-stage-funding-wellcome-trust-4876890/</loc>
		<lastmod>2016-04-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjohnson-johnson-acquire-dermocosmetics-company-neostrata-4877698/</loc>
		<lastmod>2016-04-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsec-grants-marketing-authorisation-gilead-sciences-descovy-ftaf-4875239/</loc>
		<lastmod>2016-04-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshelsinn-partners-purdue-pharma-akynzeo-distribution-licensing-rights-4875865/</loc>
		<lastmod>2023-04-18T08:09:29+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsampharma-receives-fast-track-designation-recap-4876453/</loc>
		<lastmod>2016-04-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureinhalable-insulin-a-losing-battle-4872250/</loc>
		<lastmod>2020-01-31T13:54:22+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssobi-affibody-sign-licensing-agreement-develop-therapies-related-inflammatory-diseases-4873698/</loc>
		<lastmod>2016-04-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newschembio-conduct-first-oral-fluidsaliva-poc-diagnostic-test-malaria-4874722/</loc>
		<lastmod>2016-04-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnewlink-genetics-receives-contract-option-barda-develop-ebola-vaccine-4874748/</loc>
		<lastmod>2016-04-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsirelands-allergan-acquires-us-manufacturer-topokine-therapeutics-4873055/</loc>
		<lastmod>2016-04-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslannett-yichang-develop-generic-insulin-product-us-market-4873443/</loc>
		<lastmod>2016-04-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-46-4872295/</loc>
		<lastmod>2023-04-12T06:21:36+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newskeytruda-opdivo-lead-immuno-oncology-market-4869391/</loc>
		<lastmod>2023-06-30T04:32:35+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-immunobiochem-promethera-biosciences-gemphire-therapeutics-recipharm-4871382/</loc>
		<lastmod>2016-04-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmas-this-week-chongqing-sansheng-recipharm-4871408/</loc>
		<lastmod>2016-04-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newswho-declares-europe-malaria-free-4871534/</loc>
		<lastmod>2016-04-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-and-partners-to-sequence-genomes-to-discover-new-drugs-4872110/</loc>
		<lastmod>2016-04-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/the-spread-of-the-zika-threat-and-the-response-of-the-global-pharma-industry-parallels-to-ebola-but-important-distinctions-html/</loc>
		<lastmod>2021-11-02T03:19:13+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureplaudits-due-how-a-search-through-soil-led-to-a-potent-weapon-against-parasitic-disease-4809500/</loc>
		<lastmod>2016-04-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdr-reddys-promius-launches-zembrace-symtouch-us-treat-acute-migraine-4870083/</loc>
		<lastmod>2016-04-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvie-university-chicago-collaborate-cancer-research-4870849/</loc>
		<lastmod>2021-11-22T06:11:21+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-firm-protein-sciences-partners-develop-new-zika-virus-vaccine-4871310/</loc>
		<lastmod>2016-04-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmercks-keytruda-fda-breakthrough-therapy-designation-chl-4868526/</loc>
		<lastmod>2016-04-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnhs-england-reconsider-decision-hiv-prevention-treatment-prep-4869373/</loc>
		<lastmod>2016-04-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsprobiogen-eucodis-commercialise-adc-technology-c-link-4869381/</loc>
		<lastmod>2016-04-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newswho-advisory-group-recommends-sanofis-dengue-vaccine-dengvaxia-4867481/</loc>
		<lastmod>2016-04-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsrecipharm-acquire-kemwells-cdmo-operations-us-sweden-india-4868009/</loc>
		<lastmod>2016-04-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-opens-56m-respiratory-medicines-production-plant-uk-4868041/</loc>
		<lastmod>2018-11-19T14:52:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurea-guide-to-starting-up-clinical-trials-4809314/</loc>
		<lastmod>2023-05-12T11:30:41+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsaustralian-researchers-confirm-atovaquones-ability-combat-malaria-parasite-4866186/</loc>
		<lastmod>2016-04-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-recommends-ptcs-translarna-treat-duchenne-muscular-dystrophy-4866836/</loc>
		<lastmod>2016-04-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsmismanagement-dementia-costs-uk-healthcare-system-1bn-annually-report-4867120/</loc>
		<lastmod>2016-04-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisai-wins-approval-use-aricept-dlb-treatment-philippines-4864988/</loc>
		<lastmod>2016-04-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-researchers-investigate-sperm-boosting-capability-lycopene-4865451/</loc>
		<lastmod>2016-04-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-add-new-space-advance-immuno-oncology-research-4865550/</loc>
		<lastmod>2016-04-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-ge-ventures-shanghai-fosun-pharma-cambrooke-therapeutics-4866273/</loc>
		<lastmod>2023-05-08T11:53:30+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsma-this-week-advantis-sequence-therapy-madrigal-pharma-synta-pharma-4866306/</loc>
		<lastmod>2016-04-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-identifies-fertility-app-effective-alternative-contraceptive-pill-4863631/</loc>
		<lastmod>2016-04-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsareva-med-begins-lead-212-production-us-4864134/</loc>
		<lastmod>2016-04-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnordic-nanovector-psi-develop-new-arcs-treat-single-cell-leukaemia-4864205/</loc>
		<lastmod>2016-04-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurestem-cell-printing-a-pathway-to-personalised-medicine-4809800/</loc>
		<lastmod>2016-04-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-approves-venclexta-tablets-treat-chronic-lymphocytic-leukaemia-4862396/</loc>
		<lastmod>2016-04-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsresearchers-suspect-link-between-zika-virus-acute-disseminated-encephalomyelitis-4863239/</loc>
		<lastmod>2016-04-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscelgene-commercialise-junos-cd19-programme-outside-north-america-china-4863424/</loc>
		<lastmod>2016-04-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-grants-priority-review-roches-bla-cancer-immunotherapy-atezolizumab-4861594/</loc>
		<lastmod>2016-04-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsaustralian-researchers-work-new-drugs-treat-multiple-sclerosis-pain-4861955/</loc>
		<lastmod>2016-04-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsge-ventures-mayo-clinic-set-up-new-company-digitise-gene-therapies-4862169/</loc>
		<lastmod>2023-05-08T11:53:55+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsec-approves-novartis-revolade-treat-chronic-itp-children-4860396/</loc>
		<lastmod>2016-04-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssun-pharma-obtains-us-fda-approval-bromsite-4860414/</loc>
		<lastmod>2022-02-14T08:52:20+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsaustrian-researchers-measure-nitric-oxide-concentration-human-cells-4860929/</loc>
		<lastmod>2016-04-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsec-grants-approval-bristol-myers-opdivo-treat-renal-cell-carcinoma-4859540/</loc>
		<lastmod>2016-04-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-consumer-healthcare-inaugurates-new-facility-us-4859552/</loc>
		<lastmod>2016-04-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdeals-this-week-cutis-pharma-sorrento-therapeutics-yinnan-baiyao-group-4859709/</loc>
		<lastmod>2021-12-02T05:21:46+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisai-partners-pharmstandard-localise-production-russia-4858109/</loc>
		<lastmod>2016-04-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-partners-research-capillary-stem-cells-4858271/</loc>
		<lastmod>2016-04-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-allergan-terminate-160bn-merger-deal-4858829/</loc>
		<lastmod>2016-04-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newszambon-xadago-in-belgium-mid-late-stage-parkinsons-disease-4856385/</loc>
		<lastmod>2016-04-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsipsen-dassault-systemes-3dexperience-platform-drug-discovery-4857166/</loc>
		<lastmod>2016-04-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscipher-beteflam-canada-plaque-psoriasis-4857497/</loc>
		<lastmod>2016-04-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuremarchs-top-stories-astrazenecas-faslodex-received-fda-approval-teva-acquired-rimsa-4849085/</loc>
		<lastmod>2016-04-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-worlds-biggest-generic-pharmaceutical-companies-4853429/</loc>
		<lastmod>2024-05-10T07:00:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-committee-recommends-approval-of-amicus-galafold-to-treat-fabry-disease-4855140/</loc>
		<lastmod>2023-05-22T07:17:58+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsheptares-forms-consortium-to-advance-drug-discovery-using-cryo-em-technique-4856145/</loc>
		<lastmod>2016-04-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgileads-descovy-receives-fda-approval-treat-hiv-4856154/</loc>
		<lastmod>2016-04-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-takeda-new-company-generic-medicines-japan-4853696/</loc>
		<lastmod>2016-04-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurezika-virus-tracking-an-evolving-public-health-crisis-4853902/</loc>
		<lastmod>2016-04-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-acquires-padlock-therapeutics-4854687/</loc>
		<lastmod>2016-04-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssandoz-canada-respiratory-antibiotic-4854809/</loc>
		<lastmod>2018-11-19T14:52:34+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepriority-pathways-tackling-the-worlds-unmet-clinical-needs-4807144/</loc>
		<lastmod>2016-03-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-jazz-pharmaceuticals-defitelio-hepatic-veno-occlusive-disease-4852308/</loc>
		<lastmod>2016-03-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshumanwell-puracap-to-acquire-epic-pharma-for-550m-4853498/</loc>
		<lastmod>2016-03-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-researchers-explore-ways-to-develop-new-drugs-for-use-in-space-4851481/</loc>
		<lastmod>2016-03-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsks-nucala-asthma-medicine-gets-approval-in-japan-4852118/</loc>
		<lastmod>2016-03-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-worlds-most-sold-cancer-drugs-in-2015-4852126/</loc>
		<lastmod>2016-03-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-researchers-launch-new-initiative-to-advance-cancer-and-autoimmune-disease-treatments-4849835/</loc>
		<lastmod>2016-03-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssun-pharma-to-acquire-novartis-prescription-brands-in-japan-for-293m-4850678/</loc>
		<lastmod>2016-03-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-worlds-top-selling-diabetes-drugs-4852441/</loc>
		<lastmod>2024-05-10T07:19:47+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-45-4850481/</loc>
		<lastmod>2023-04-12T06:21:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbayer-regeneron-combination-therapy-treat-eye-diseases-4848500/</loc>
		<lastmod>2016-03-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-breaks-ground-diabetes-medicine-production-facility-us-4849511/</loc>
		<lastmod>2016-03-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssun-pharma-astrazeneca-type-2-diabetes-medicine-india-4847264/</loc>
		<lastmod>2021-10-27T12:29:24+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsleo-pharma-wins-approval-use-enstilar-psoriasis-vulgaris-treatment-eu-4846657/</loc>
		<lastmod>2016-03-22T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsarjuna-natural-invests-research-programme-explore-benefits-turmeric-curcumin-4846667/</loc>
		<lastmod>2016-03-22T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/new-energy-is-injected-into-drg-based-hospital-payments-html/</loc>
		<lastmod>2021-11-02T03:19:16+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshelsinn-and-eisai-extend-partnership-for-prevention-of-cinv-4843881/</loc>
		<lastmod>2016-03-21T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsprofectus-vyriad-to-develop-oncolytic-rvsv-vaccines-to-treat-cancer-4843767/</loc>
		<lastmod>2016-03-21T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurechina-a-pharmaceutical-giant-emerges-4809240/</loc>
		<lastmod>2016-03-20T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsvictorian-government-grant-20m-fund-cancer-research-4842719/</loc>
		<lastmod>2016-03-20T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-acquire-rights-orexos-ox-cli-programme-4842766/</loc>
		<lastmod>2016-03-20T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-dice-molecules-develop-oral-treatments-replace-monoclonal-antibodies-4841428/</loc>
		<lastmod>2016-03-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbayers-kovaltry-receives-fda-approval-treat-haemophilia-a-4842393/</loc>
		<lastmod>2016-03-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsblueprint-medicines-roche-partner-advance-cancer-immunotherapy-4840995/</loc>
		<lastmod>2016-03-16T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-drugmaker-vectura-and-skyepharma-merge-441-3m-deal-4841347/</loc>
		<lastmod>2016-03-16T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newseu-approves-10m-funds-research-zika-virus-4840226/</loc>
		<lastmod>2016-03-15T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsimmunogenx-acquires-alvine-pharmaceuticals-assets-4840418/</loc>
		<lastmod>2016-03-15T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-frazier-healthcare-form-new-company-develop-urology-gynaecology-therapeutics-4838515/</loc>
		<lastmod>2022-11-14T13:44:49+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizers-xalkori-receives-fda-approval-treat-ros1-positive-metastatic-non-small-cell-lung-cancer-4838672/</loc>
		<lastmod>2016-03-14T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurehow-can-the-pharma-industry-fight-climate-change-4814240/</loc>
		<lastmod>2016-03-13T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdr-reddys-tr-pharm-partner-commercialise-biosimilar-drugs-turkey-4837656/</loc>
		<lastmod>2016-03-13T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newseuropean-medicines-agency-start-review-gileads-cancer-medicine-zydelig-4838189/</loc>
		<lastmod>2016-03-13T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurecould-farm-dust-be-key-to-developing-a-vaccine-against-asthma-4809451/</loc>
		<lastmod>2016-03-10T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-tevas-40-5bn-acquisition-allergan-generics-4836092/</loc>
		<lastmod>2016-03-10T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmitsubishis-tobacco-based-vaccine-promising-alternative-egg-based-versions-says-globaldata-4836195/</loc>
		<lastmod>2016-03-10T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsindias-lupin-completes-880m-acquisition-us-firm-gavis-4834750/</loc>
		<lastmod>2016-03-09T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsipsen-peptimimesis-partner-develop-therapeutic-peptides-oncology-4835526/</loc>
		<lastmod>2016-03-09T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-pasteur-msd-terminate-vaccines-jv-europe-4833495/</loc>
		<lastmod>2016-03-08T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newswho-recommends-measures-prevent-zika-virus-4833662/</loc>
		<lastmod>2016-03-08T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuredrug-side-effects-big-pharmas-inconvenient-truth-4809331/</loc>
		<lastmod>2016-03-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsema-launches-new-prime-scheme-accelerate-development-promising-medicines-4832103/</loc>
		<lastmod>2016-03-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newssmc-denies-nhs-scotland-access-perjeta-breast-cancer-drug-4832244/</loc>
		<lastmod>2016-03-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurefebruarys-top-stories-us-researchers-developed-mini-brains-novartis-received-fda-approval-afinitor-tablets-4827744/</loc>
		<lastmod>2016-03-06T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazenecas-faslodex-receives-fda-approval-new-indication-4830063/</loc>
		<lastmod>2016-03-06T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsroyalty-pharma-buys-royalty-rights-uclas-cancer-drug-xtandi-1-14bn-4831114/</loc>
		<lastmod>2016-03-06T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/cost-driver-or-cost-saver-obamas-take-on-precision-medicine-html/</loc>
		<lastmod>2021-11-02T03:19:20+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-pharmaceutical-acquires-mexicos-rimsa-23bn-4829413/</loc>
		<lastmod>2016-03-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsus-researchers-discover-new-stem-cell-advance-regenerative-medicines-4829881/</loc>
		<lastmod>2016-03-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuredifferent-agendas-the-gppharma-divide-4809365/</loc>
		<lastmod>2016-03-02T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-identifies-blocks-molecule-maintains-sciatic-nerve-pain-4828211/</loc>
		<lastmod>2016-03-02T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsamfar-calls-additional-funding-support-hivaids-research-nih-4828638/</loc>
		<lastmod>2016-03-02T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-confirm-causal-link-between-zika-virus-guillain-barr-syndrome-4826814/</loc>
		<lastmod>2016-03-01T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-sell-european-rights-moventig-prostrakan-4827178/</loc>
		<lastmod>2016-03-01T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-roches-gazyva-treat-follicular-lymphoma-4825114/</loc>
		<lastmod>2016-02-29T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-deploys-veeva-vault-rim-solutions-4825701/</loc>
		<lastmod>2016-02-29T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/pharmaceutical-industry-gears-up-for-data-disclosure-on-payments-to-healthcare-professionals-html/</loc>
		<lastmod>2021-11-02T03:19:23+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-receives-fda-approval-afinitor-tablets-treat-progressive-non-functional-net-4823803/</loc>
		<lastmod>2022-02-15T08:08:02+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsec-approves-astrazenecas-brilique-treat-patients-history-heart-attack-4824421/</loc>
		<lastmod>2022-07-11T08:57:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurewhat-would-brexit-mean-for-uk-clinical-research-4824855/</loc>
		<lastmod>2016-02-28T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbaxalta-precision-biosciences-develop-car-t-cell-therapies-4822309/</loc>
		<lastmod>2016-02-25T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-identifies-human-protein-triggers-juvenile-arthritis-4822984/</loc>
		<lastmod>2016-02-25T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-receives-fda-approval-xeljanz-xr-treat-rheumatoid-arthritis-4820969/</loc>
		<lastmod>2016-02-24T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsuk-researchers-genetic-technology-gut-bacteria-combat-zika-virus-4821623/</loc>
		<lastmod>2016-02-24T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsseven-pharmaceutical-majors-join-together-improve-clinical-trials-parkinsons-4819803/</loc>
		<lastmod>2016-02-23T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmyriad-genetics-expands-research-collaborations-abbvie-tesaro-merck-4820338/</loc>
		<lastmod>2016-02-23T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsks-viiv-healthcare-acquires-bristol-myers-squibbs-hiv-rd-assets-4818410/</loc>
		<lastmod>2016-02-22T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-researchers-develop-new-technique-create-artificial-arteries-drug-testing-4818901/</loc>
		<lastmod>2016-02-22T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-44-4814226/</loc>
		<lastmod>2023-04-12T06:26:06+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslupin-gavis-sell-two-generic-drugs-gain-merger-approval-4817233/</loc>
		<lastmod>2016-02-21T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-grants-breakthrough-status-novartis-pkc412-treat-flt3-mutated-aml-4817408/</loc>
		<lastmod>2016-02-21T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscipla-eu-completes-550m-acquisition-us-firms-invagen-exelan-4815858/</loc>
		<lastmod>2016-02-18T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-researchers-develop-mini-brains-study-neurological-disorders-4816313/</loc>
		<lastmod>2016-02-18T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuresick-dying-and-on-a-placebo-could-we-do-away-with-it-altogether-4809470/</loc>
		<lastmod>2016-02-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-grants-breakthrough-status-roches-ocrelizumab-treat-ppms-4814427/</loc>
		<lastmod>2016-02-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsstudy-shows-experimental-t-cell-therapy-puts-cancer-patients-remission-4815282/</loc>
		<lastmod>2016-02-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizers-subsidiary-wyeth-pay-7846m-settle-medicaid-rebates-issues-4813116/</loc>
		<lastmod>2016-02-16T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newswho-recommends-control-measures-tackle-zika-virus-4813837/</loc>
		<lastmod>2016-02-16T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbiocons-rosuvastatin-calcium-tablets-gets-eu-approval-to-treat-hyperlipidemia-4811839/</loc>
		<lastmod>2023-05-09T07:52:47+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-refuses-to-approve-mercks-zetia-and-vytorin-medicines-4812218/</loc>
		<lastmod>2016-02-15T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscrown-licences-cell-based-prostate-cancer-models-uks-university-york-4810439/</loc>
		<lastmod>2016-02-14T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssandoz-buys-rights-pfizers-infliximab-biosimilar-eea-4810529/</loc>
		<lastmod>2016-02-14T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-medimmune-lilly-join-u-m-discover-new-ckd-treatments-4808957/</loc>
		<lastmod>2016-02-11T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-status-onl-therapeutics-onl1204-treat-retinal-detachment-4809056/</loc>
		<lastmod>2016-02-11T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-status-amarantus-eltoprazine-treat-pd-lid-4807378/</loc>
		<lastmod>2016-02-10T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-offers-72bn-acquire-swedens-meda-4807739/</loc>
		<lastmod>2016-02-10T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsadaptimmunes-enhanced-t-cell-therapy-fda-breakthrough-status-synovial-sarcoma-4806163/</loc>
		<lastmod>2016-02-09T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsvbi-vaccines-gsk-evaluate-lpv-platform-new-vaccines-improved-stability-4806357/</loc>
		<lastmod>2016-02-09T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-establishes-task-force-fast-track-trials-zika-virus-4804988/</loc>
		<lastmod>2016-02-08T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-status-epizymes-tazemetostat-treat-malignant-rhabdoid-tumours-4805049/</loc>
		<lastmod>2016-02-08T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurejanuarys-top-stories-zika-virus-shire-acquired-baxalta-4802150/</loc>
		<lastmod>2016-02-08T04:41:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-rejects-vertexs-snda-kalydeco-treat-cystic-fibrosis-people-two-older-4804117/</loc>
		<lastmod>2016-02-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspromius-sernivo-spray-fda-approval-treat-moderate-plaque-psoriasis-4804146/</loc>
		<lastmod>2016-02-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-receives-fda-approval-single-dose-emend-injection-4803329/</loc>
		<lastmod>2016-02-04T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-proposes-1-1bn-investment-address-opioid-abuse-heroin-use-4803501/</loc>
		<lastmod>2016-02-04T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurea-matter-of-trust-online-pharmacies-and-patient-data-4788075/</loc>
		<lastmod>2022-07-11T08:57:45+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-government-allocates-1m-fast-track-zika-virus-research-4801551/</loc>
		<lastmod>2016-02-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazenecas-tagrisso-lung-cancer-drug-gets-approval-europe-4801588/</loc>
		<lastmod>2016-02-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-acquires-55-stake-acerta-pharma-4bn-4800346/</loc>
		<lastmod>2016-02-02T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-adaptimmune-expand-cancer-immunotherapy-alliance-4800440/</loc>
		<lastmod>2016-02-02T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/has-of-cards-looking-for-the-new-president-of-frances-high-health-authority-html/</loc>
		<lastmod>2021-11-02T03:19:27+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-pfizer-develop-portolas-andexanet-alfa-japan-4798984/</loc>
		<lastmod>2016-02-01T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-validates-gileads-type-ii-variation-application-truvada-reduce-risk-hiv-1-infection-4799057/</loc>
		<lastmod>2016-02-01T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisais-halaven-injection-gets-fda-approval-treat-advanced-liposarcoma-4797823/</loc>
		<lastmod>2016-01-31T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsallergan-astrazeneca-develop-atm-avi-antibiotic-resistant-gram-negative-infections-4797880/</loc>
		<lastmod>2016-01-31T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newszika-virus-expected-infect-four-million-people-americas-who-4796661/</loc>
		<lastmod>2016-01-28T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-collaborates-iran-food-drug-administration-4796753/</loc>
		<lastmod>2016-01-28T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscrt-msd-develop-inhibitors-prmt5-cancer-blood-disorders-4795492/</loc>
		<lastmod>2016-01-27T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-takedas-dexilant-solutab-treat-gastroesophageal-reflux-disease-4795532/</loc>
		<lastmod>2016-01-27T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-nice-approves-astrazenecas-new-ovarian-cancer-drug-lynparza-4793987/</loc>
		<lastmod>2016-01-26T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsresident-us-state-virginia-tests-positive-zika-virus-4794092/</loc>
		<lastmod>2016-01-26T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspharmaceutical-majors-join-hands-leading-universities-apollo-therapeutics-fund-4793373/</loc>
		<lastmod>2016-01-25T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsirelands-shire-acquires-us-biotech-dyax-59bn-4792340/</loc>
		<lastmod>2016-01-24T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-allergans-botox-treat-lower-limb-spasticity-adults-4792503/</loc>
		<lastmod>2016-01-24T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsamgen-receives-fda-approval-kyprolis-combination-therapy-treat-multiple-myeloma-4791623/</loc>
		<lastmod>2016-01-21T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newspharma-companies-urge-governments-take-collective-action-drug-resistant-infections-4791747/</loc>
		<lastmod>2016-01-21T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-43-4789326/</loc>
		<lastmod>2023-04-12T06:25:18+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvies-venetoclax-rituximab-combination-fda-breakthrough-therapy-status-treat-rr-cll-4790241/</loc>
		<lastmod>2016-01-20T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsupsher-smith-saniona-develop-new-therapeutics-neurological-disorders-4790288/</loc>
		<lastmod>2016-01-20T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsacorda-acquire-finlands-biopharmaceutical-firm-biotie-363m-4788959/</loc>
		<lastmod>2016-01-19T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovozymes-spins-off-biopharma-business-albumedix-4789051/</loc>
		<lastmod>2016-01-19T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-telling-telomere-working-towards-cancer-prediction-4647369/</loc>
		<lastmod>2016-01-18T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscentauri-therapeutics-buys-alphamer-immuno-therapeutics-technology-altermune-4787665/</loc>
		<lastmod>2016-01-18T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmedicinovas-ibudilast-gets-fda-rare-paediatric-disease-status-treat-krabbe-disease-4787839/</loc>
		<lastmod>2021-12-02T12:02:02+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-grants-priority-review-eisais-new-drug-application-anticancer-drug-lenvatinib-4786507/</loc>
		<lastmod>2016-01-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-fda-approves-cosentyx-ankylosing-spondylitis-psoriatic-arthritis-treatment-4786688/</loc>
		<lastmod>2016-01-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscalibr-pfizer-develop-new-antibody-based-therapeutic-agents-heart-failure-4784610/</loc>
		<lastmod>2016-01-14T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringer-arena-develop-new-drugs-psychiatric-diseases-4784521/</loc>
		<lastmod>2021-12-02T07:51:39+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdelmar-md-anderson-accelerate-development-anti-cancer-drug-val-083-4784603/</loc>
		<lastmod>2023-05-31T05:55:05+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureinnovations-in-asthma-treatment-4718853/</loc>
		<lastmod>2016-01-12T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-warp-drive-develop-new-oncology-therapies-antibiotics-4783444/</loc>
		<lastmod>2016-01-12T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvies-leukaemia-drug-venetoclax-accepted-review-us-europe-4783547/</loc>
		<lastmod>2016-01-12T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsshire-agrees-acquire-baxalta-32bn-4774600/</loc>
		<lastmod>2016-01-11T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-agrees-acquire-uks-iomet-pharma-4774684/</loc>
		<lastmod>2016-01-11T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgrnenthal-and-akashi-to-develop-ht-100-treat-dmd-patients-4773167/</loc>
		<lastmod>2022-07-11T08:57:46+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-innate-develop-new-cancer-drugs-4773236/</loc>
		<lastmod>2016-01-10T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/complexities-in-personalised-medicine-key-to-new-directions-in-oncology-html/</loc>
		<lastmod>2021-11-02T03:19:31+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-and-enterome-discover-microbiome-targets-across-multiple-gastrointestinal-disorders-4770067/</loc>
		<lastmod>2016-01-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsviiv-janssen-develop-new-two-drug-injectable-regimen-treat-hiv-1-infection-4771551/</loc>
		<lastmod>2016-01-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscomplix-merck-develop-cell-penetrating-alphabodies-treat-cancer-4768734/</loc>
		<lastmod>2016-01-06T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-status-innocrins-seviteronel-treat-metastatic-crpc-4770025/</loc>
		<lastmod>2016-01-06T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-little-pink-pill-breakthrough-for-women-or-barely-beneficial-4719211/</loc>
		<lastmod>2022-11-30T14:31:59+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-validates-sunesis-marketing-authorisation-application-vosaroxin-treat-aml-4767521/</loc>
		<lastmod>2016-01-05T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsrhythm-camurus-develop-fluidcrystal-setmelanotide-formulation-4768629/</loc>
		<lastmod>2016-01-05T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/feature2015-the-years-biggest-pharmaceutical-technology-stories-4765922/</loc>
		<lastmod>2016-01-05T05:03:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsswlstg-free-app-lithium-medicine-management-4767002/</loc>
		<lastmod>2016-01-04T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbaxalta-collaborate-symphogen-16bn-immuno-oncology-deal-4767483/</loc>
		<lastmod>2016-01-04T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslixte-lead-cancer-compound-taipei-medical-university-hcc-treatment-4766285/</loc>
		<lastmod>2016-01-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-orphan-drug-status-gbt-once-daily-therapy-sickle-cell-disease-4766489/</loc>
		<lastmod>2016-01-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/pricing-and-market-access/chinas-economy-and-prospects-of-tcm-html/</loc>
		<lastmod>2021-11-02T03:19:34+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsseasons-greetings-pharma-4762080/</loc>
		<lastmod>2015-12-23T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-pasteurs-dengue-vaccine-dengvaxia-gets-approval-philippines-4761353/</loc>
		<lastmod>2015-12-22T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsintrexon-and-janssen-develop-new-therapies-type-2-diabetes-4761591/</loc>
		<lastmod>2015-12-22T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshalozyme-lilly-partner-to-develop-new-drugs-using-enhanze-platform-4760090/</loc>
		<lastmod>2015-12-21T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbayer-and-crispr-form-jv-develop-new-treatments-serious-genetic-diseases-4760274/</loc>
		<lastmod>2015-12-21T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-biggest-pharmaceutical-company-takeovers-in-2015-4757175/</loc>
		<lastmod>2021-11-01T08:55:38+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsemas-revised-eudravigilance-access-policy-increases-access-adverse-reaction-reports-4758678/</loc>
		<lastmod>2015-12-20T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmartindale-pharma-launches-first-oral-liquid-suspension-formula-riluzole-uk-4758886/</loc>
		<lastmod>2015-12-20T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssec-charges-turing-pharmaceuticals-ceo-over-securities-fraud-4757297/</loc>
		<lastmod>2015-12-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgalapagos-gilead-sign-2bn-deal-develop-inflammatory-drug-filgotinib-4757622/</loc>
		<lastmod>2021-12-02T09:49:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-buy-takedas-respiratory-business-575m-expands-chinese-operations-4756124/</loc>
		<lastmod>2018-11-19T14:52:43+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-lilly-boehringer-basaglar-insulin-glargine-product-treat-diabetes-4756271/</loc>
		<lastmod>2015-12-16T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharmas-big-jobs-rescue-4719217/</loc>
		<lastmod>2015-12-15T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-divests-us-rights-entocort-perrigo-380m-4754675/</loc>
		<lastmod>2021-11-24T05:38:11+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-signs-five-year-deal-comic-relief-fight-malaria-4754785/</loc>
		<lastmod>2015-12-15T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsakebia-and-mitsubishi-to-develop-and-commercialise-ckd-drug-vadadustat-in-asia-4753410/</loc>
		<lastmod>2015-12-14T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-in-talks-for-181bn-asset-swap-with-boehringer-ingelheim-4753533/</loc>
		<lastmod>2015-12-14T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newswellstats-vistogard-receives-fda-approval-to-treat-chemotherapy-overdose-patients-4752351/</loc>
		<lastmod>2022-07-11T08:57:47+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newscourt-rules-uk-firm-reckitt-benckisers-nurofen-made-misleading-pain-relief-claims-4752673/</loc>
		<lastmod>2015-12-13T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurenovembers-top-stories-uk-sets-up-fund-to-tackle-malaria-pfizer-agrees-to-buy-allergan-4744143/</loc>
		<lastmod>2015-12-11T06:56:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-42-4749436/</loc>
		<lastmod>2023-04-12T06:21:50+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizers-snda-ibrance-gets-fda-priority-review-hr-her2-metastatic-breast-cancer-4751224/</loc>
		<lastmod>2015-12-10T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssun-pharma-partners-weizmann-institute-idis-develop-brain-stroke-drug-4750097/</loc>
		<lastmod>2015-12-09T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofis-dengue-vaccine-dengvaxia-gets-approval-mexico-4749935/</loc>
		<lastmod>2015-12-09T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-us-drug-quality-and-security-act-working-towards-a-better-supply-chain-4719200/</loc>
		<lastmod>2022-07-11T08:57:48+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-priority-review-pfizer-snda-xalkori-treat-ros1-positive-metastatic-nsclc-4748518/</loc>
		<lastmod>2023-06-20T04:50:25+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsalexions-kanuma-gets-fda-approval-treat-lysosomal-acid-lipase-deficiency-4748643/</loc>
		<lastmod>2015-12-08T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscelgene-and-astrazeneca-begin-fusion-clinical-development-programme-of-durvalumab-4747116/</loc>
		<lastmod>2015-12-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-and-cour-to-develop-new-therapies-to-treat-celiac-disease-4747443/</loc>
		<lastmod>2015-12-07T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjnj-completes-takeover-novira-therapeutics-4745852/</loc>
		<lastmod>2015-12-06T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-validates-gileads-maa-for-fdc-of-sofosbuvirvelpatasvir-to-treat-hcv-4746084/</loc>
		<lastmod>2015-12-06T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newszymeworks-and-gsk-to-develop-new-fc-engineered-antibody-therapeutics-4744764/</loc>
		<lastmod>2021-11-25T09:46:13+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspluristem-fukushima-medical-university-evaluate-plx-r18-cells-radiation-treatment-4744875/</loc>
		<lastmod>2015-12-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsks-nucala-gets-marketing-authorisation-europe-treat-eosinophilic-asthma-4743435/</loc>
		<lastmod>2015-12-02T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmedicines-patent-pool-liverpool-university-develop-new-hiv-nanomedicines-4742112/</loc>
		<lastmod>2015-12-01T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsroche-upsher-smith-partner-develop-new-vap-1-inhibitor-4742298/</loc>
		<lastmod>2015-12-01T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsheptares-and-pfizer-develop-new-medicines-directed-gpcr-targets-4740926/</loc>
		<lastmod>2015-11-30T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjanssen-seeks-approval-stelara-us-europe-treat-crohns-disease-4741026/</loc>
		<lastmod>2015-11-30T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslannett-acquires-ucbs-generic-unit-kremers-urban-123bn-4739821/</loc>
		<lastmod>2015-11-29T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-issues-complete-response-letter-bms-sbla-opdivo-treat-advanced-melanoma-4739849/</loc>
		<lastmod>2015-11-29T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureamlps-a-promising-alternative-to-antibiotics-4718679/</loc>
		<lastmod>2015-11-26T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringers-praxbind-european-approval-specific-reversal-pradaxa-4738780/</loc>
		<lastmod>2015-11-26T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsalliance-pharma-buy-sinclairs-non-aesthetics-business-for-132m-4738929/</loc>
		<lastmod>2015-11-26T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-heptares-discover-new-small-molecule-cgrp-antagonists-treat-migraine-4737883/</loc>
		<lastmod>2022-11-08T13:58:45+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsallergan-partners-rugen-develop-new-drugs-cns-disorders-4737933/</loc>
		<lastmod>2022-11-24T11:59:51+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-offers-150m-funding-first-dementia-research-institute-4736767/</loc>
		<lastmod>2015-11-24T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-gets-marketing-authorisation-europe-expanded-indication-volibris-treat-pah-4736939/</loc>
		<lastmod>2015-11-24T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-41-4736126/</loc>
		<lastmod>2023-04-12T06:30:42+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-sets-up-1bn-ross-fund-tackle-malaria-4735331/</loc>
		<lastmod>2015-11-23T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-agrees-to-acquire-allergan-in-160bn-deal-4735737/</loc>
		<lastmod>2015-11-23T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsliberia-confirms-three-new-ebola-cases-4734164/</loc>
		<lastmod>2015-11-22T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakedas-ninlaro-gets-fda-approval-treat-multiple-myeloma-4734302/</loc>
		<lastmod>2015-11-22T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-ucl-begin-brain-imaging-study-new-neurodegenerative-disease-treatments-4732961/</loc>
		<lastmod>2015-11-19T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-uct-develop-new-drug-discovery-platform-malaria-4733198/</loc>
		<lastmod>2015-11-19T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-accepts-sandozs-bla-biosimilar-pegfilgrastim-treat-non-myeloid-cancer-4731563/</loc>
		<lastmod>2023-03-08T09:50:35+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-and-pfizers-avelumab-gets-fda-breakthrough-status-metastatic-merkel-cell-carcinoma-4731662/</loc>
		<lastmod>2023-02-03T08:51:59+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmorphotek-gothenburg-university-develop-farletuzumab-ovarian-cancer-4730268/</loc>
		<lastmod>2015-11-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenentech-exercise-rights-wet-amd-treatment-fovista-under-novartis-agreement-4730669/</loc>
		<lastmod>2015-11-17T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjanssen-biotechs-darzalex-drug-gets-fda-approval-treat-multiple-myeloma-4729317/</loc>
		<lastmod>2015-11-16T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsomnio-prometic-partner-develop-new-drug-chronic-wounds-4729439/</loc>
		<lastmod>2023-03-23T12:16:05+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newszambons-xadago-gets-swissmedic-approval-treat-parkinsons-disease-4720169/</loc>
		<lastmod>2015-11-15T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbaxalta-receives-european-approval-obizur-treat-haemophilia-a-4720191/</loc>
		<lastmod>2015-11-15T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-cotellic-zelboraf-combination-to-treat-advanced-melanoma-4718620/</loc>
		<lastmod>2015-11-12T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringer-to-invest-11bn-in-rd-to-accelerate-discovery-of-new-drugs-4716810/</loc>
		<lastmod>2015-11-11T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsleo-pharma-agrees-to-acquire-astellas-global-dermatology-portfolio-for-675m-4716861/</loc>
		<lastmod>2015-11-11T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-accepts-immunes-ind-for-bertilimumab-to-treat-bullous-pemphigoid-4716040/</loc>
		<lastmod>2023-02-14T09:47:15+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastellas-agrees-to-buy-ocata-therapeutics-for-379m-4715213/</loc>
		<lastmod>2015-11-09T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-gets-fda-breakthrough-status-for-sd-809-to-treat-tardive-dyskinesia-4715261/</loc>
		<lastmod>2023-07-19T05:29:04+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsoctobers-top-stories-clinical-trial-to-test-aspirins-ability-treatment-for-liposarcoma-4710940/</loc>
		<lastmod>2022-07-11T08:57:48+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-agrees-to-acquire-zs-pharma-for-27bn-4714180/</loc>
		<lastmod>2015-11-08T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsignyta-acquires-rights-to-lillys-taladegib-oncology-programme-4714247/</loc>
		<lastmod>2015-11-08T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgileads-single-tablet-regimen-genvoya-gets-fda-approval-to-treat-hiv-1-infection-4712946/</loc>
		<lastmod>2015-11-05T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-lexicon-develop-diabetes-drug-sotagliflozin-4713120/</loc>
		<lastmod>2015-11-05T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-senate-launches-investigation-drug-pricing-four-pharma-firms-4711447/</loc>
		<lastmod>2023-04-06T10:23:30+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-glaxosmithklines-asthma-drug-nucala-4711523/</loc>
		<lastmod>2015-11-04T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuretrialling-the-pharma-industrys-new-abuse-deterrent-painkillers-4698342/</loc>
		<lastmod>2015-11-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-agrees-buy-us-biotechnology-firm-cardioxyl-207bn-4710268/</loc>
		<lastmod>2015-11-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-and-biontech-partner-to-develop-five-new-cancer-immunotherapies-4710311/</loc>
		<lastmod>2015-11-03T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsirelands-shire-agrees-buy-us-biotech-dyax-59bn-4708815/</loc>
		<lastmod>2023-05-09T07:22:14+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-serono-selvita-discover-new-drugs-cancer-metabolism-4708926/</loc>
		<lastmod>2015-11-02T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscelgene-european-approval-vidaza-treat-elders-aml-4708116/</loc>
		<lastmod>2015-11-01T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdaiichi-plexxikons-csf-1r-pnhibitor-pexidartinib-gets-fda-breakthrough-status-treat-tgct-4708182/</loc>
		<lastmod>2015-11-01T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-40-4707236/</loc>
		<lastmod>2023-04-12T06:24:47+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-and-gsk-to-develop-pcmm-prototype-for-oral-solid-dose-4706400/</loc>
		<lastmod>2015-10-29T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-utibron-neohaler-fda-approval-treat-airflow-obstruction-copd-patients-4706444/</loc>
		<lastmod>2022-07-11T08:57:50+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsigenica-medimmune-enter-into-oncology-research-agreement-4705246/</loc>
		<lastmod>2015-10-28T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgilead-seeks-fda-approval-sofosbuvirvelpatasvir-combination-treat-six-genotypes-hcv-4705287/</loc>
		<lastmod>2015-10-28T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-amgens-imlygic-as-first-oncolytic-viral-therapy-melanoma-4703907/</loc>
		<lastmod>2015-10-27T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newskite-partners-alpine-develop-new-immunotherapies-cancer-4703977/</loc>
		<lastmod>2015-10-27T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureamericas-21st-century-cure-act-fit-for-purpose-4647453/</loc>
		<lastmod>2015-10-26T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscapsugel-introduces-entrinsic-drug-delivery-technology-4702758/</loc>
		<lastmod>2015-10-26T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-accepts-tymes-ind-application-oncology-drug-candidate-4702848/</loc>
		<lastmod>2015-10-26T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-committee-issues-positive-opinion-expand-indication-gsks-volibris-treat-pah-4701231/</loc>
		<lastmod>2015-10-25T18:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjanssens-yondelis-gets-fda-approval-treat-unresectable-metastatic-lps-lms-4701275/</loc>
		<lastmod>2023-07-27T10:07:46+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsclinical-trial-uk-assess-whether-aspirin-can-prevent-cancer-return-4699960/</loc>
		<lastmod>2015-10-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuregood-gut-feeling-using-bioengineered-bacteria-to-treat-diseases-4647468/</loc>
		<lastmod>2015-10-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-opens-224m-drug-manufacturing-facility-russia-4699306/</loc>
		<lastmod>2015-10-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-pharmacy2u-fined-130000-for-selling-patients-personal-data-4699052/</loc>
		<lastmod>2022-07-11T08:57:50+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdomainex-imperial-discover-new-therapies-myocardial-infarction-4699164/</loc>
		<lastmod>2015-10-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-status-pfizer-leukaemia-drug-inotuzumab-ozogamicin-4697877/</loc>
		<lastmod>2015-10-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsregeneron-invest-350m-limerick-iops-bioprocessing-campus-ireland-4697997/</loc>
		<lastmod>2015-10-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbasileas-isavuconazole-european-approval-invasive-aspergillosis-mucormycosis-4696677/</loc>
		<lastmod>2023-05-30T04:20:03+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringers-praxbind-gets-fda-approval-specific-reversal-agent-pradaxa-4696706/</loc>
		<lastmod>2015-10-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuresafe-simple-secure-top-trends-in-pharma-packaging-4647356/</loc>
		<lastmod>2023-05-12T09:58:40+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-recommends-bms-daklinza-treat-hepatitis-c-virus-4695183/</loc>
		<lastmod>2015-10-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsemisphere-to-develop-oral-formulations-four-novo-nordisk-molecules-4695241/</loc>
		<lastmod>2015-10-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-federal-prosecutors-investigate-valeants-drug-pricing-mechanism-4694045/</loc>
		<lastmod>2015-10-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-relaunches-brand-identity-4694591/</loc>
		<lastmod>2015-10-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslilly-imaginab-research-new-t-cell-based-immuno-oncology-therapies-4693024/</loc>
		<lastmod>2015-10-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsshire-gets-fda-fast-track-status-intravenous-administration-of-cinryze-4693167/</loc>
		<lastmod>2023-05-09T07:35:22+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsscottish-medicines-consortium-approves-herceptin-treat-patients-gastric-cancer-4691555/</loc>
		<lastmod>2015-10-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-seeks-european-approval-chlorhexidine-gel-prevent-umbilical-cord-infections-newborns-4691940/</loc>
		<lastmod>2015-10-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsseptembers-top-stories-mylans-bid-to-buy-perrigo-treatment-for-dengue-4690067/</loc>
		<lastmod>2015-10-11T20:34:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-bristol-myers-opdivo-injection-treat-metastatic-nsclc-4690442/</loc>
		<lastmod>2015-10-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsroche-agrees-buy-us-biotech-adheron-580m-4690570/</loc>
		<lastmod>2015-10-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastellas-licences-lamp-vax-products-immunomic-worldwide-commercialisation-4690835/</loc>
		<lastmod>2015-10-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-status-merck-pfizers-carcinoma-drug-avelumab-4689017/</loc>
		<lastmod>2023-02-03T08:52:56+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureglobaldatas-shaan-thakerar-discusses-the-novartis-drug-trial-controversy-4647407/</loc>
		<lastmod>2022-07-11T08:57:51+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-high-force-research-durham-university-patent-new-stem-cell-compounds-4688330/</loc>
		<lastmod>2015-10-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-priority-review-bristol-myers-daklinza-sndas-4687171/</loc>
		<lastmod>2015-10-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-drug-distributor-amerisourcebergen-agrees-buy-pharmedium-25bn-4687242/</loc>
		<lastmod>2015-10-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-pay-146m-settle-sec-charges-fcpa-violations-4686116/</loc>
		<lastmod>2015-10-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsalkermes-aristada-gets-fda-approval-treat-schizophrenia-4686241/</loc>
		<lastmod>2015-10-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssandozs-bla-biosimilar-etanercept-gets-fda-acceptance-4684991/</loc>
		<lastmod>2015-10-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsallergan-humana-enter-research-collaboration-improve-health-outcomes-4685023/</loc>
		<lastmod>2015-10-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsvetter-upgrade-manufacturing-facilities-4684050/</loc>
		<lastmod>2015-10-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureamr-research-funding-the-elephant-in-the-room-4670298/</loc>
		<lastmod>2015-09-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastellas-chromocell-develop-new-therapies-neuropathic-pain-4683084/</loc>
		<lastmod>2015-09-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-pharma-completes-acquisition-of-novartis-healthcares-vaccines-business-4683437/</loc>
		<lastmod>2021-06-01T10:36:30+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstevas-copaxone-japanese-approval-multiple-sclerosis-relapse-prevention-4682194/</loc>
		<lastmod>2015-09-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsendo-acquires-par-pharmaceutical-8bn-4681072/</loc>
		<lastmod>2015-09-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-and-regenerons-anti-cholesterol-drug-praluent-gets-european-approval-4681401/</loc>
		<lastmod>2023-04-14T07:58:40+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslondon-moorfields-eye-hospital-first-patient-stem-cell-therapy-wet-amd-4681651/</loc>
		<lastmod>2022-07-11T08:57:52+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsisraels-teva-agrees-buy-us-smart-inhaler-firm-gecko-health-innovations-4680018/</loc>
		<lastmod>2022-11-30T15:21:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-gets-european-marketing-authorisation-asthma-drug-mepolizumab-4680029/</loc>
		<lastmod>2015-09-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-launches-sayana-press-self-injectable-contraceptive-uk-4678858/</loc>
		<lastmod>2015-09-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsessa-fda-start-clinical-development-prostate-cancer-treatment-4679292/</loc>
		<lastmod>2015-09-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-39-4694710/</loc>
		<lastmod>2023-04-12T06:29:08+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurefake-medicines-are-we-on-the-verge-of-a-pandemic-4647433/</loc>
		<lastmod>2015-09-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmedimmune-tanabe-develop-pbd-based-drug-conjugates-cancer-treatment-4677784/</loc>
		<lastmod>2015-09-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-firm-turing-reduce-price-toxoplasmosis-drug-daraprim-amid-protests-4677794/</loc>
		<lastmod>2023-04-06T10:23:23+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstaiho-gets-fda-approval-colorectal-cancer-drug-lonsurf-4676775/</loc>
		<lastmod>2015-09-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsacelrxs-pain-drug-zalviso-gets-marketing-authorisation-europe-4676833/</loc>
		<lastmod>2015-09-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsregeneron-barda-jointly-develop-new-ebola-antibody-treatment-4675470/</loc>
		<lastmod>2015-09-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsani-pharma-buy-mercks-two-ndas-75m-4675497/</loc>
		<lastmod>2015-09-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-new-heart-failure-drug-entresto-gets-swissmedic-approval-4674247/</loc>
		<lastmod>2015-09-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenmabs-sbla-ofatumumab-gets-fda-priority-review-treat-relapsed-cll-4674345/</loc>
		<lastmod>2015-09-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgonorrhoea-outbreak-across-north-england-triggers-nationwide-health-alert-4673421/</loc>
		<lastmod>2015-09-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsamgen-agrees-buy-dutch-firm-dezima-pharma-155bn-deal-4673492/</loc>
		<lastmod>2015-09-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureuk-pharma-getting-ahead-of-the-brexit-debate-4670958/</loc>
		<lastmod>2015-09-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscelgene-nurix-develop-new-therapies-oncology-inflammation-immunology-4672614/</loc>
		<lastmod>2015-09-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsindias-sun-pharma-agrees-buy-insite-vision-4671861/</loc>
		<lastmod>2015-09-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-researchers-find-combo-three-antibiotic-drugs-kills-staph-infections-4672282/</loc>
		<lastmod>2015-09-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-bids-27bn-to-acquire-irish-otc-firm-perrigo-4670426/</loc>
		<lastmod>2015-09-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-acquires-amgens-us-biologics-bulk-manufacturing-plant-4671008/</loc>
		<lastmod>2015-09-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-firm-gencia-and-japans-takeda-develop-new-magr-drugs-4669702/</loc>
		<lastmod>2015-09-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-serono-invests-65m-expand-rd-facility-germany-4669774/</loc>
		<lastmod>2015-09-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureaugusts-top-stories-viagra-women-shires-30bn-offer-baxalta-4668431/</loc>
		<lastmod>2021-10-28T12:21:32+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsswiss-drugmaker-actelion-confirms-preliminary-discussions-acquire-zs-pharma-4668783/</loc>
		<lastmod>2015-09-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsuniversity-of-queensland-scientists-identify-potential-treatment-dengue-fever-4669041/</loc>
		<lastmod>2015-09-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscanadas-concordia-healthcare-to-acquire-uk-drugmaker-amdipharm-for-35bn-4668036/</loc>
		<lastmod>2015-09-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsantenatal-iron-supplementation-does-not-increase-malaria-risk-says-study-4666586/</loc>
		<lastmod>2015-09-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsus-firm-purdue-acquires-vm-pharmas-vm-902a-trka-programme-213m-4666864/</loc>
		<lastmod>2015-09-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsindia-rejects-pfizers-patent-application-arthritis-drug-tofacitinib-4665350/</loc>
		<lastmod>2015-09-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsucsf-study-shows-voriconazole-increases-risk-skin-cancer-lung-transplant-recipients-4665605/</loc>
		<lastmod>2015-09-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsrelief-rights-merck-develop-atexakin-alfa-peripheral-neuropathies-treatment-4665940/</loc>
		<lastmod>2021-12-01T12:36:01+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscipla-eu-to-acquire-us-firms-invagen-and-exelan-for-550m-4664330/</loc>
		<lastmod>2015-09-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazenecas-expanded-indication-brilinta-gets-fda-treat-acute-coronary-syndrome-4664407/</loc>
		<lastmod>2015-09-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-completes-17bn-acquisition-of-hospira-4663440/</loc>
		<lastmod>2015-09-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslannett-buy-belgian-drugmaker-ucbs-generic-unit-kremers-urban-123bn-4662366/</loc>
		<lastmod>2015-09-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsvaleant-develop-commercialise-astrazenecas-psoriasis-drug-brodalumab-4662580/</loc>
		<lastmod>2015-09-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-amgen-develop-new-drugs-treat-alzheimers-migraine-4661277/</loc>
		<lastmod>2015-09-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-gains-rights-acquire-promedior-125bn-4661461/</loc>
		<lastmod>2015-09-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-collaborates-with-google-life-sciences-team-to-improve-diabetes-care-4660054/</loc>
		<lastmod>2015-08-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisai-and-purdue-partner-to-develop-lemborexan-for-insomnia-4660230/</loc>
		<lastmod>2023-03-30T10:25:29+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuresouth-africa-the-long-road-to-state-owned-pharma-manufacturing-4647452/</loc>
		<lastmod>2015-08-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-38-4658541/</loc>
		<lastmod>2023-04-12T06:35:30+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscelgene-acquires-biopharmaceutical-firm-receptos-for-72bn-4658191/</loc>
		<lastmod>2015-08-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringer-eli-lilly-receive-fda-approval-for-synjardy-to-treat-type-2-diabetes-4658197/</loc>
		<lastmod>2015-08-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssucampo-to-acquire-japans-r-tech-ueno-for-278m-4657186/</loc>
		<lastmod>2021-11-22T08:18:38+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-to-develop-2bn-new-production-facilities-in-us-and-denmark-4657389/</loc>
		<lastmod>2015-08-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuremalaria-research-breakthrough-raises-hopes-of-a-1-cure-4647248/</loc>
		<lastmod>2015-08-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmorphosys-immatics-collaborate-to-develop-antibody-based-therapeutics-for-solid-cancers-4656011/</loc>
		<lastmod>2015-08-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsmayo-clinic-researchers-reprogramme-cancer-cells-back-to-normal-4656118/</loc>
		<lastmod>2015-08-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnhs-england-recommends-janssens-situro-to-treat-mdr-tb-in-adult-patients-4654849/</loc>
		<lastmod>2015-08-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsexelixis-cabozantinib-gets-fda-breakthrough-therapy-status-for-renal-cell-carcinoma-4654867/</loc>
		<lastmod>2021-12-02T09:43:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-purchases-remaining-rights-of-cancer-drug-ofatumumab-from-gsk-for-1bn-4653884/</loc>
		<lastmod>2015-08-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsseres-receives-fda-orphan-drug-status-for-ser-109-to-prevent-cdi-in-adults-4654054/</loc>
		<lastmod>2015-08-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscancer-patients-miss-out-on-personalised-treatments-in-england-cancer-research-uk-4652847/</loc>
		<lastmod>2015-08-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscempras-solithromycin-receives-fda-fast-track-designation-to-treat-cabp-4652953/</loc>
		<lastmod>2015-08-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurelisten-up-the-first-wave-of-hearing-loss-treatments-4647135/</loc>
		<lastmod>2022-12-20T10:37:28+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-status-to-corbus-resunab-to-treat-systemic-sclerosis-4651607/</loc>
		<lastmod>2022-11-30T14:46:35+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsvaleant-plans-to-acquire-female-viagra-addyi-drugmaker-sprout-for-1bn-4651882/</loc>
		<lastmod>2015-08-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfenex-receives-1435m-contract-develop-new-anthrax-vaccine-4650314/</loc>
		<lastmod>2023-04-04T08:02:22+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssprouts-addyi-obtains-fda-approval-treat-sexual-dysfunction-women-4650345/</loc>
		<lastmod>2015-08-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-aveo-oncology-partner-develop-av-380-related-antibodies-4649226/</loc>
		<lastmod>2015-08-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsamag-pharmaceuticals-acquires-cord-blood-registry-700m-4649387/</loc>
		<lastmod>2023-05-15T05:55:16+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-genmabs-duobody-technology-develop-bispecific-antibodies-4648043/</loc>
		<lastmod>2021-12-02T07:49:02+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbaxter-water-streets-cefazolin-injection-2gm-premix-obtains-fda-approval-4648187/</loc>
		<lastmod>2015-08-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscmc-path-mvi-develop-monoclonal-antibodies-malaria-infection-4647076/</loc>
		<lastmod>2015-08-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newschinas-wuxi-pharmatech-signs-33bn-merger-agreement-4647174/</loc>
		<lastmod>2015-08-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureclinigen-unlocking-the-ethical-supply-of-unlicensed-medicines-4647372/</loc>
		<lastmod>2015-08-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-seeks-fda-approval-sd-809-treat-chorea-associated-hd-4646160/</loc>
		<lastmod>2015-08-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringer-circuit-partner-develop-new-medicines-obesity-4646320/</loc>
		<lastmod>2015-08-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjanssen-poseida-partner-to-use-centyrin-technology-to-develop-car-therapies-4645132/</loc>
		<lastmod>2015-08-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-shuts-down-north-carolina-facility-detecting-legionnaires-bacteria-4645356/</loc>
		<lastmod>2023-03-23T06:25:21+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsinovio-medimmune-collaborate-develop-cancer-vaccine-products-4644120/</loc>
		<lastmod>2015-08-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-receives-orphan-drug-status-gl-2045-treat-cidp-4644303/</loc>
		<lastmod>2023-02-22T11:15:51+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscma-accuses-pfizer-and-flynn-pharma-of-overpricing-anti-epilepsy-drug-4642971/</loc>
		<lastmod>2015-08-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-evotec-and-apeiron-partner-to-develop-new-immuno-oncology-therapies-4642984/</loc>
		<lastmod>2015-08-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurejuly-top-pharmaceutical-2015-4642369/</loc>
		<lastmod>2023-05-10T04:21:08+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-heptares-partner-to-develop-new-immuno-oncology-treatments-4641921/</loc>
		<lastmod>2015-08-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsaprecia-receives-fda-approval-for-3d-printed-spritam-drug-for-epilepsy-4641931/</loc>
		<lastmod>2015-08-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-gets-european-approval-17bn-hospira-acquisition-4640545/</loc>
		<lastmod>2015-08-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuks-synbicite-provides-fund-prokarium-develop-new-vaccine-chlamydia-4640566/</loc>
		<lastmod>2015-08-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscsl-acquires-novartis-global-influenza-vaccine-business-275m-4639386/</loc>
		<lastmod>2015-08-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsshire-offers-30bn-acquire-drugmaker-baxalta-4639402/</loc>
		<lastmod>2015-08-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsshire-agrees-buy-foresight-biotherapeutics-300m-4638228/</loc>
		<lastmod>2023-02-28T04:57:25+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-acquire-majority-stake-genomic-analysis-firm-immuneering-4638239/</loc>
		<lastmod>2015-08-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-isis-develop-cardiovascular-metabolic-kidney-drugs-4637138/</loc>
		<lastmod>2015-08-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-bayers-finacea-treat-papulopustular-rosacea-4637261/</loc>
		<lastmod>2015-08-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisais-lenvima-gets-fda-breakthrough-therapy-status-renal-cell-carcinoma-4636104/</loc>
		<lastmod>2015-07-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvie-receives-european-approval-humira-treat-hidradenitis-suppurativa-4636109/</loc>
		<lastmod>2015-07-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshikma-buy-boehringers-roxane-generic-units-265bn-4635015/</loc>
		<lastmod>2015-07-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-acquire-israels-ccam-biotherapeutics-605m-4635021/</loc>
		<lastmod>2015-07-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-limits-use-bms-daklinz-treat-hepatitis-c-infection-uk-4633925/</loc>
		<lastmod>2015-07-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenzyme-acquire-astrazenecas-rare-disease-medicine-caprelsa-300m-4633948/</loc>
		<lastmod>2015-07-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsisraels-teva-buy-allergan-generics-405bn-4632761/</loc>
		<lastmod>2015-07-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-regeneron-partner-develop-new-antibody-cancer-treatments-4632773/</loc>
		<lastmod>2015-07-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsirelands-allergan-buy-drugmaker-naurex-560m-4631641/</loc>
		<lastmod>2015-07-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslupin-to-buy-gavis-pharmaceuticals-for-880m-4630576/</loc>
		<lastmod>2015-07-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbaxalta-acquires-oncasper-portfolio-900m-4630596/</loc>
		<lastmod>2015-07-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newschmp-recommends-gsks-mosquirix-vaccine-prevent-malaria-young-children-4630961/</loc>
		<lastmod>2015-07-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-37-4628942/</loc>
		<lastmod>2023-04-12T06:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshorizon-increases-offer-acquire-pain-treatments-maker-depomed-4629497/</loc>
		<lastmod>2015-07-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-genmab-seek-fda-approval-ofatumumab-treat-relapsed-cll-4629508/</loc>
		<lastmod>2015-07-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbms-receives-european-approval-nivolumab-treat-metastatic-sq-nsclc-4628509/</loc>
		<lastmod>2015-07-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-sandoz-cleared-launch-generic-version-amgens-neupogen-4628707/</loc>
		<lastmod>2015-07-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurecrystal-clear-could-unlocking-proteins-provide-new-cures-for-anxiety-4583924/</loc>
		<lastmod>2015-07-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdelcaths-melphalan-fda-orphan-drug-status-treat-cholangiocarcinoma-4627416/</loc>
		<lastmod>2015-07-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsuk-researchers-repair-damaged-liver-using-stem-cells-4627553/</loc>
		<lastmod>2015-07-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsvaleant-buy-amoun-pharmaceutical-800m-4626414/</loc>
		<lastmod>2015-07-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvie-c2ns-humanised-anti-tau-antibody-obtains-fda-orphan-drug-status-psp-4626445/</loc>
		<lastmod>2015-07-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsamri-buys-spanish-gadea-pharmaceutical-group-174m-4625420/</loc>
		<lastmod>2015-07-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstillotts-completes-acquisition-astrazenecas-entocort-rights-outside-us-215m-4625432/</loc>
		<lastmod>2021-11-22T09:18:37+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscelgene-to-buy-receptos-for-72bn-4624291/</loc>
		<lastmod>2015-07-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfive-prime-therapeutics-and-inhibrx-partner-gitr-antibody-programme-4624305/</loc>
		<lastmod>2015-07-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsblocking-dna-pkcs-prevents-spread-tumour-cells-say-researchers-4623317/</loc>
		<lastmod>2015-07-15T04:34:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-astrazenecas-iressa-treat-egfr-mutation-positive-nsclc-4623297/</loc>
		<lastmod>2015-07-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuregood-gut-feeling-using-bioengineered-bacteria-to-treat-disease-4583740/</loc>
		<lastmod>2015-07-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-recommends-daiichis-anti-blood-clotting-drug-edoxaban-dvt-pe-4622200/</loc>
		<lastmod>2015-07-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsuks-teenager-develops-new-test-for-alzheimers-disease-4622468/</loc>
		<lastmod>2015-07-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvies-imbruvica-obtains-european-approval-treat-blood-cancer-wm-4621110/</loc>
		<lastmod>2015-07-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsveloxis-envarsus-xr-gets-fda-approval-treat-kidney-transplant-patients-4621135/</loc>
		<lastmod>2022-07-11T08:57:53+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsimmunovaccine-pharmathene-develop-new-anthrax-vaccine-4620046/</loc>
		<lastmod>2015-07-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstillott-acquire-astrazenecas-entocor-medicine-rights-outside-us-215m-4620130/</loc>
		<lastmod>2021-11-24T05:36:28+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-rocky-road-ahead-for-burgeoning-biosimilars-4616368/</loc>
		<lastmod>2021-10-26T06:29:55+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshorizon-pharma-offers-3bn-acquire-depomed-4618936/</loc>
		<lastmod>2015-07-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgarlic-treats-antimicrobial-resistant-urinary-tract-infections-says-new-study-4619080/</loc>
		<lastmod>2022-08-02T09:05:08+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsjunes-top-stories-head-transplant-10bn-funds-london-pharma-companies-4617874/</loc>
		<lastmod>2015-07-08T05:55:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-novartis-new-entresto-heart-failure-medicine-4617940/</loc>
		<lastmod>2015-07-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsallergan-acquire-mercks-cgrp-migraine-programme-250m-4617952/</loc>
		<lastmod>2015-07-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscardinal-health-acquires-harvard-drug-group-11bn-4616994/</loc>
		<lastmod>2021-10-21T10:54:29+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscatabasis-obtains-fda-fast-track-status-cat-1004-treat-dmd-4617020/</loc>
		<lastmod>2015-07-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureregenerating-medicine-an-ocean-of-possibility-within-a-sea-of-red-tape-4583643/</loc>
		<lastmod>2015-07-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslupin-buys-russian-pharmaceutical-firm-biocom-4615765/</loc>
		<lastmod>2015-07-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-seeks-fda-approval-xeljanz-modified-release-tablets-treat-ra-4615794/</loc>
		<lastmod>2015-07-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringers-spiolto-respimat-copd-therapy-approved-in-european-countries-4614981/</loc>
		<lastmod>2015-07-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-launches-opdivo-uk-advanced-melanoma-4614327/</loc>
		<lastmod>2015-07-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsviiv-healthcare-chinas-desano-sign-manufacturing-deal-new-hiv-drug-tivicay-4614507/</loc>
		<lastmod>2015-07-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-eolas-develop-orexin-1-receptor-antagonist-addiction-4613429/</loc>
		<lastmod>2023-04-20T02:20:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstheravance-vibativ-bactericidal-antibiotic-receives-russian-approval-4613524/</loc>
		<lastmod>2021-11-25T10:50:58+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsablynx-taisho-develop-commercialise-anti-tnf-nanobody-japan-4612452/</loc>
		<lastmod>2015-06-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsamag-pharmaceuticals-buy-cord-blood-registry-700m-4612468/</loc>
		<lastmod>2023-05-15T05:54:59+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuredrug-promotion-does-self-regulation-work-4606510/</loc>
		<lastmod>2015-06-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-agrees-acquire-drug-development-firm-spinifex-pharmaceuticals-4611349/</loc>
		<lastmod>2015-06-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseu-chmp-recommends-roches-perjeta-pre-surgery-breast-cancer-4611421/</loc>
		<lastmod>2015-06-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslondon-mayor-plans-create-10bn-megafund-new-drugs-therapies-4610288/</loc>
		<lastmod>2015-06-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsucl-led-study-shows-cancer-drugs-delay-ageing-process-fruit-flies-4610389/</loc>
		<lastmod>2023-01-19T06:39:43+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstexas-researchers-antihypertensive-drug-stop-drug-alcohol-addiction-4609285/</loc>
		<lastmod>2022-09-27T10:22:35+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssiemens-biontech-team-up-personalised-cancer-vaccines-4609333/</loc>
		<lastmod>2015-06-24T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-36-4607504/</loc>
		<lastmod>2023-04-12T06:34:29+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsswedish-researchers-impotence-drugs-do-not-cause-malignant-melanoma-4608296/</loc>
		<lastmod>2015-06-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsims-health-foundation-medicine-partner-advance-precision-medicines-cancer-4608363/</loc>
		<lastmod>2015-06-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-purchase-gsks-nimenrix-mencevax-vaccines-130m-4606789/</loc>
		<lastmod>2015-06-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newskite-and-bluebird-co-develop-second-generation-tcr-therapy-products-4607239/</loc>
		<lastmod>2015-06-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureabivax-a-new-weapon-in-the-fight-against-hepatitis-b-4583663/</loc>
		<lastmod>2015-06-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsaimmunes-ar101-receives-fda-breakthrough-therapy-status-treat-peanut-allergy-4605994/</loc>
		<lastmod>2015-06-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbms-receives-european-approval-for-opdivo-to-treat-advanced-melanoma-4606000/</loc>
		<lastmod>2015-06-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseli-lilly-dana-farber-partner-advance-development-cancer-medicines-4605015/</loc>
		<lastmod>2015-06-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-sandoz-introduces-generic-version-teva-multiple-sclerosis-drug-4605037/</loc>
		<lastmod>2015-06-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsallergan-buy-kythera-biopharmaceuticals-21bn-4603862/</loc>
		<lastmod>2015-06-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-to-open-independent-research-institute-medicine-development-us-4603872/</loc>
		<lastmod>2015-06-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-breaks-ground-new-consumer-products-production-facility-china-4602698/</loc>
		<lastmod>2015-06-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-university-of-michigan-partner-advance-treatments-ckd-4602716/</loc>
		<lastmod>2015-06-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureleveraging-big-data-to-solve-pharmas-hard-to-cure-problems-4583712/</loc>
		<lastmod>2018-08-06T10:32:10+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsitalian-neurosurgeon-plans-first-human-head-transplant-4601583/</loc>
		<lastmod>2015-06-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-receives-european-approval-for-17bn-acquisition-of-sigma-aldrich-4601619/</loc>
		<lastmod>2015-06-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsseres-obtains-fda-breakthrough-therapy-status-product-candidate-ser-109-4600534/</loc>
		<lastmod>2015-06-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-approves-novartis-promacta-treat-itp-children-six-years-older-4600544/</loc>
		<lastmod>2015-06-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsaltan-pharma-buys-spanish-injectable-drugmaker-ges-group-4599574/</loc>
		<lastmod>2015-06-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfdas-padac-recommends-gsks-mepolizumab-to-treat-adults-severe-asthma-4599600/</loc>
		<lastmod>2015-06-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfdas-emdac-recommends-sanofi-regenerons-alirocumab-hypercholesterolemia-4598555/</loc>
		<lastmod>2023-04-14T07:58:57+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenentechs-actemra-gets-fda-breakthrough-therapy-status-scleroderma-4598567/</loc>
		<lastmod>2022-11-30T14:46:24+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharmacogenomics-its-all-in-the-genes-4583429/</loc>
		<lastmod>2015-06-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsampharmas-recap-obtains-fda-ema-orphan-drug-status-hypophosphatasia-4597435/</loc>
		<lastmod>2015-06-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslycera-celgene-partner-advance-development-immune-modulators-4597462/</loc>
		<lastmod>2015-06-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-introduces-generic-version-gsks-asthma-therapy-uk-4596253/</loc>
		<lastmod>2015-06-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspozen-buy-tribute-pharmaceuticals-canada-146m-4596270/</loc>
		<lastmod>2015-06-08T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscardinal-health-to-buy-harvard-drug-group-for-11bn-4595258/</loc>
		<lastmod>2015-06-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjanssen-seeks-fda-approval-daratumumab-treat-multiple-myeloma-4595281/</loc>
		<lastmod>2015-06-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsmays-top-stories-mylans-offer-perrigo-new-hiv-cure-centre-4594642/</loc>
		<lastmod>2015-06-05T10:25:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenzyme-enzyme-replacement-therapy-receives-fda-breakthrough-therapy-status-4594254/</loc>
		<lastmod>2022-12-03T08:44:19+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssprouts-addyi-gets-fda-nod-treat-hsdd-premenopausal-women-4594266/</loc>
		<lastmod>2023-01-19T07:46:13+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnice-recommends-boehringers-nintedanib-plus-docetaxel-to-treat-nsclc-4593137/</loc>
		<lastmod>2015-06-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshalozyme-and-abbvie-partner-for-enhanze-platform-4593346/</loc>
		<lastmod>2015-06-03T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsperrigo-acquire-gsks-otc-portfolio-4592055/</loc>
		<lastmod>2015-06-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-status-lipocines-lpcn-1107-prevent-preterm-birth-4592067/</loc>
		<lastmod>2015-06-02T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurestemming-the-tide-for-lung-cancer-4583890/</loc>
		<lastmod>2015-06-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsactavis-acquires-uk-auden-mckenzie-306m-4590861/</loc>
		<lastmod>2015-06-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseuropean-commission-grants-approval-eisais-thyroid-cancer-drug-lenvima-4590875/</loc>
		<lastmod>2015-06-01T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmerck-seeks-fda-approval-grazoprevirelbasvir-treat-hcv-gt1-4-6-4589769/</loc>
		<lastmod>2015-05-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizers-rapamune-obtains-fda-approval-lymphangioleiomyomatosis-4589794/</loc>
		<lastmod>2015-05-31T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssoligenix-signs-collaboration-agreement-develop-heat-stable-ebola-vaccine-4588710/</loc>
		<lastmod>2015-05-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-introduces-type-2-diabetes-treatment-zafatek-japan-4588730/</loc>
		<lastmod>2015-05-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featureresearchkit-unlocking-patient-data-with-apples-open-source-app-4583838/</loc>
		<lastmod>2015-05-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringers-once-daily-stiolto-respimat-receives-fda-approval-copd-4587538/</loc>
		<lastmod>2015-05-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsactavis-viberzi-gets-fda-approval-treat-ibs-d-4587558/</loc>
		<lastmod>2015-05-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmercks-simponi-gets-chmp-positive-opinion-treat-nr-axial-spa-4586430/</loc>
		<lastmod>2023-03-12T17:01:35+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsabbvie-acquires-biopharmaceutical-firm-pharmacyclics-21bn-4586436/</loc>
		<lastmod>2015-05-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsema-committee-recommends-approval-amgens-repatha-treat-high-cholesterol-4585577/</loc>
		<lastmod>2015-05-25T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsneurovive-sanofi-develop-commercialise-ciclomulsion-south-korea-4585617/</loc>
		<lastmod>2021-11-22T12:35:35+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsindias-strides-buy-aspens-australian-generic-pharmaceutical-business-4583399/</loc>
		<lastmod>2021-11-22T09:20:39+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsaura-biosciences-au-011-drug-receives-fda-orphan-drug-status-uveal-melanoma-4583422/</loc>
		<lastmod>2023-06-07T04:16:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseisai-introduces-anticancer-agent-lenvima-japan-4582502/</loc>
		<lastmod>2015-05-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsirelands-endo-acquire-par-pharmaceutical-8bn-4581440/</loc>
		<lastmod>2015-05-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsachillion-janssen-develop-hepatitis-c-virus-assets-4581531/</loc>
		<lastmod>2022-12-12T14:50:52+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-develop-new-285m-biologics-manufacturing-facility-sweden-4580389/</loc>
		<lastmod>2015-05-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsablynx-genzyme-partner-multiple-sclerosis-research-project-4580646/</loc>
		<lastmod>2015-05-18T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspernixs-migraine-drug-treximet-gets-fda-approval-treat-paediatric-patients-4579328/</loc>
		<lastmod>2015-05-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnantpharma-buy-sorrento-igdrasol-4579487/</loc>
		<lastmod>2015-05-17T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslupin-buys-brazilian-pharmaceutical-firm-medqumica-4578219/</loc>
		<lastmod>2015-05-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscortendo-antisense-develop-atl1103-endocrinology-applications-4578369/</loc>
		<lastmod>2015-05-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssanofi-selecta-partner-develop-new-immunotherapy-celiac-disease-4576860/</loc>
		<lastmod>2015-05-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbaxter-acquires-sigma-taus-oncaspar-product-portfolio-900m-4576989/</loc>
		<lastmod>2015-05-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsalnylams-revusiran-gets-fda-orphan-drug-designation-attr-amyloidosis-4582488/</loc>
		<lastmod>2015-05-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsendo-acquires-aspen-subsidiarys-portfolio-branded-generic-products-4575668/</loc>
		<lastmod>2015-05-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmercks-evofosfamide-obtains-fda-fast-track-designation-pancreatic-cancer-4575696/</loc>
		<lastmod>2015-05-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-purchases-minority-interest-dutch-firm-ampharma-4574422/</loc>
		<lastmod>2015-05-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newseli-lilly-biontech-develop-new-cancer-immunotherapies-4574724/</loc>
		<lastmod>2015-05-11T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsaprils-top-stories-tevas-offer-to-mylan-takeda-settles-with-us-4572692/</loc>
		<lastmod>2015-05-11T03:08:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovartis-receives-eu-approval-for-zykadia-treat-alk-nsclc-4573370/</loc>
		<lastmod>2015-05-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-unc-chapel-hill-hiv-cure-centre-company-4573629/</loc>
		<lastmod>2015-05-10T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssiegfried-acquire-basfs-pharmaceuticals-business-270m-4572248/</loc>
		<lastmod>2021-12-02T08:25:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newshorizon-pharma-acquires-hyperion-therapeutics-11bn-4572361/</loc>
		<lastmod>2015-05-07T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsalexion-to-buy-synageva-biopharma-for-84bn-4571044/</loc>
		<lastmod>2015-05-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-to-retain-its-stake-in-hiv-drugmaker-viiv-healthcare-4571155/</loc>
		<lastmod>2015-05-06T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbayer-isis-partner-develop-antisense-drug-thrombosis-4570020/</loc>
		<lastmod>2015-05-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-completes-purchase-us-based-auspex-35bn-4570034/</loc>
		<lastmod>2015-05-05T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsesperare-receives-ema-orphan-drug-designation-dmd-drug-rimeporide-4568946/</loc>
		<lastmod>2015-05-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-develop-new-haemophilia-treatment-manufacturing-facility-denmark-4569015/</loc>
		<lastmod>2015-05-04T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-offers-acquire-perrigo-34bn-4566883/</loc>
		<lastmod>2021-10-25T09:49:05+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgsk-and-theravance-receive-fda-approval-asthma-drug-breo-ellipta-4567001/</loc>
		<lastmod>2015-04-30T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-35-4567232/</loc>
		<lastmod>2023-04-12T06:35:36+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-to-pay-24bn-to-settle-actos-drug-claims-in-us-4566009/</loc>
		<lastmod>2015-04-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsfda-grants-approval-generic-version-antipsychotic-drug-abilify-4566108/</loc>
		<lastmod>2015-04-29T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgenzymes-gzsar402671-receives-fda-fast-track-designation-fabry-disease-4564937/</loc>
		<lastmod>2023-05-22T07:22:04+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazenecas-heart-drug-brilinta-receives-fda-priority-review-designation-4565027/</loc>
		<lastmod>2015-04-28T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscelgene-buy-drug-discovery-firm-quanticel-485m-4563858/</loc>
		<lastmod>2015-04-27T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastellas-introduces-aspergillosis-and-mucormycosis-treatment-cresemba-us-4563973/</loc>
		<lastmod>2023-05-30T04:20:20+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featuredrugs-from-dirt-digging-up-a-pharma-treasure-trove-4551269/</loc>
		<lastmod>2015-04-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsinnate-pharma-astrazeneca-develop-iph2201-immuno-oncology-4562693/</loc>
		<lastmod>2023-06-30T04:32:47+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-tevas-proposed-combination-transform-generic-drugs-area-says-globaldata-4562926/</loc>
		<lastmod>2015-04-26T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastellas-potenza-partner-develop-immune-oncology-therapeutics-4561730/</loc>
		<lastmod>2015-04-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmylan-introduces-generic-sofosbuvir-400mg-tablets-india-4561943/</loc>
		<lastmod>2015-04-23T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizers-xalkori-gets-fda-breakthrough-therapy-designation-ros1-positive-nsclc-4560633/</loc>
		<lastmod>2015-04-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newscymabay-mbx-8025-receives-fda-orphan-drug-designation-hyperlipoproteinemia-4560864/</loc>
		<lastmod>2015-04-22T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazeneca-use-roches-bina-gms-drug-development-programmes-4559436/</loc>
		<lastmod>2015-04-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsteva-offers-40bn-acquire-drugmaker-mylan-4559687/</loc>
		<lastmod>2015-04-21T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newslupin-introduces-hepatic-encephalopathy-treatment-zaxine-canada-4558527/</loc>
		<lastmod>2015-04-20T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-sells-its-entire-stake-indias-sun-pharma-325bn-4558662/</loc>
		<lastmod>2021-10-27T12:29:17+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurethe-amr-war-cabinet-a-united-front-against-superbugs-4549176/</loc>
		<lastmod>2021-04-19T13:57:31+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newstakeda-cira-partner-ips-cell-research-4557394/</loc>
		<lastmod>2015-04-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/uncategorized/newsrxis-samcyprone-receives-fda-orphan-drug-designation-treat-malignant-melanoma-4557614/</loc>
		<lastmod>2015-04-19T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsastrazenecas-tremelimumab-receives-fda-approval-treat-mesothelioma-4556286/</loc>
		<lastmod>2022-09-09T10:45:24+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsgeovax-nih-develop-vaccines-against-ebola-marburg-viruses-4556383/</loc>
		<lastmod>2015-04-16T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbms-lexicon-select-development-candidate-neuropathic-pain-4555235/</loc>
		<lastmod>2015-04-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsamgen-receives-fda-approval-chronic-heart-failure-medicine-corlanor-4555383/</loc>
		<lastmod>2015-04-15T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newssobis-elocta-obtains-swiss-orphan-drug-designation-haemophilia-a-4554297/</loc>
		<lastmod>2015-04-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newspfizer-rgi-jdrf-partner-develop-new-therapy-type-1-diabetes-4554461/</loc>
		<lastmod>2015-04-14T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsboehringer-and-hydra-biosciences-to-discover-small-molecule-trp-inhibitors-4553237/</loc>
		<lastmod>2015-04-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsjanssen-ichor-develop-dna-based-vaccine-products-chronic-hepatitis-b-4553417/</loc>
		<lastmod>2015-04-13T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/features/featurehealthy-appetite-the-biggest-pharmaceutical-takeovers-in-the-last-ten-years-4543965/</loc>
		<lastmod>2015-04-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsreatas-bardoxolone-methyl-receives-fda-orphan-drug-designation-treat-pah-4552241/</loc>
		<lastmod>2021-11-25T10:14:39+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsmedivir-cancer-research-uk-partner-develop-new-cancer-drugs-4552395/</loc>
		<lastmod>2015-04-12T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.pharmaceutical-technology.com/news/newsbms-acquires-biotechnology-firm-flexus-biosciences-for-125bn-4551113/</loc>
		<lastmod>2015-04-09T17:30:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.2</priority>
	</url>
</urlset><!-- Request ID: 8c0594665e69566793c97c901d5b8d34; Queries for sitemap: 3863; Total queries: 3893; Seconds: 8.91; Memory for sitemap: 56MB; Total memory: 70MB -->
